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The common bottlenose dolphin, Tursiops truncatus, is one of the most recognized 
marine mammal species.  These mammals now serve as a sentinel species to evaluate and 
monitor ecosystem health in critical coastal regions.  For example, the Atlantic bottlenose 
dolphin health and environmental risk assessment project (HERA) has studied these 
animals over the past 20 years from the Charleston harbor in South Carolina (CH) and the 
Indian River Lagoon (IRL) in Florida, USA, as part of an overall approach to 
understanding links between Oceans and Human Health (OHH).  Environmental 
pressures, assessed as a combination of pollution exposure, habitat quality, and exposure 
to infectious diseases, are now considered the primary driver for the health of dolphins.  
Specifically, emerging infectious diseases and zoonotic pathogens have become a serious 
and complex threat to humans, animals, and environmental health.  Streptococcus 
agalactiae is an emerging environmental disease that can also affect 
immunocompromised humans.  One means to assessing exposure to such diseases is by 
examining seroconversion or seropositivity.  Serum antibody levels have seldom been 
used with environmental species because of the general lack of immunological reagents 
and the intense labor associated with these methods.  In this study, monoclonal antibodies 
(mAb) were generated against bottlenose dolphin IgG, IgM in bull shark (Carcharhinus 
leucas) and spotted eagle ray (Aetobatus narinari), and an on-hand mAb against 
loggerhead sea turtle (Caretta caretta) IgY was used.  Serum or plasma samples were 
collected from animals inhabiting the same location. These reagents were used to 
calculate relative antibody titers against S. agalactiae at a dilution of 1:200 and compare 
 iii 
these data to antibody activities calculated over a range of serum dilutions.  This part of 
the study demonstrates that antibody activity data are more sensitive than simple relative 
titers when determining antibody responses to S. agalactiae in all four species and across 
the immunoglobulin spectrum (IgM, IgY, and IgG) of marine aquatic vertebrates.  The 
generated monoclonal antibody against bottlenose dolphin IgG was used to compare 
relative titers to antibody activities in bottlenose dolphin serum samples collected over 
the past 20 years of the HERA project to compare Charleston Harbor animals to Indian 
River Lagoon animals.  Responses in animals from the GA Aquarium and the managed 
marine mammal program (US Navy) were also examined.  There were few differences 
between the groups in terms of relative antibody titers against S. agalactiae, but 
calculated antibody activity data demonstrate differences.  Previously published studies 
from our lab demonstrate differences in antibody responses against several other highly 
pathogenic bacteria when comparing the dolphin groups over the years.  Compared to 
those data, it appears that bottlenose dolphins are not currently burdened by S. 
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1.1 Tursiops truncatus background 
 The common bottlenose dolphin (Tursiops truncatus), a member of the Order 
Cetacea, is one of the best-known and most recognized marine mammal species (Vollmer 
and Rosel, 2013).  In the United States, they are not endangered or threatened but 
protected under the Marine Mammal Protection Act (National Marine Fisheries Service, 
2021b).  Two distinct ecotypes have been identified; an offshore, deep, cold-water 
ecotype and a coastal, warm, shallow ecotype (Mead and Potter, 1995).  The bottlenose 
dolphin is widely distributed and can be found in temperate to tropical regions.  They can 
be found on the coasts of oceanic islands and all the major continents (Reynolds, 2000).   
Bottlenose dolphin sexual maturity varies from population-to-population with 
previous studies estimating that males mature around 7 to 17 years of age and females 
mature between 5 to 14 years of age.  Females typically have a 12-month gestation period 
followed by an 18-month lactation period for captive dolphins.  Dolphin calves usually 
will stay with their mothers for about 3 to 6 years.  Their diet varies by habitat (Gannon 
and Waples, 2004) and feeds on prey such as crustaceans, squid, and fish (National 
Marine Fisheries Service, 2021a).  They are of economic importance for many coastal 
communities providing millions of dollars each year from the whale-watching industry 
(Parsons et al., 2015).  Also, they are a significant contributor to the employment and 







Figure 1.1.  The geographical range of the common bottlenose dolphin (Tursiops 
truncatus) (International Whaling Commission, 2021).   
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1.2 Bottlenose Dolphin Threats 
Bottlenose dolphins encounter many anthropogenic threats, pollutants and 
pathogens, underwater noise, and collisions with shipping vessels and boats (Fair and 
Becker, 2000).  Pathogens are ever-present in the marine environment, and there are 
many different emerging viral, bacterial, fungal, and protozoal diseases that these 
organisms face every day.   
Harmful algal blooms (HABs) have been associated with mass mortality events of 
dolphins, in addition to many other marine mammals (Flewelling et al., 2005; Geraci et 
al., 1989; Jessup et al., 2007).  HABs produce harmful neurotoxins and can produce a 
wide range of biotoxins, including saxitoxins, brevetoxins, domoic acid, and okadaic 
acid.  These toxins cause paralytic, neurotoxic, amnesic, and diarrhetic shellfish 
poisoning in humans, respectively (Landsberg, 2002).  These HABs continue to be 
problematic worldwide and pose a significant threat to human and ecosystem health 
(Geraci et al., 1989) 
Anthropogenic toxicants have been demonstrated to be an unrelenting issue for 
the marine environment.  Bottlenose dolphins are exposed to many different persistent 
inorganic and organo-halogen toxicants that can bioaccumulate in the marine 
environment.  The ability of these toxicants to bioaccumulate results in high tissue 
concentrations in bottlenose dolphins, amongst many other top marine predators (Bossart, 
2011).  Bottlenose dolphins have large fat stores, which allows for lipophilic toxicants to 
accumulate (Fair et al., 2010) and later become mobilized during periods of lactation, 
starvation, and fasting (Tanabe, 2002).  High levels of contaminants have been 
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documented in marine mammals that are from coastal regions with dense human 
populations and increased amounts of industrial and agricultural activities (Aguilar et al., 
2002; Fair et al., 2010; Houde et al., 2005).  Some of the toxicants that have been 
documented in bottlenose dolphins include polychlorinated biphenyls, which are used in 
a variety of industrial and commercial purposes (Fair et al., 2010; Houde et al., 2006), 
perfluorinated chemicals used in water, strain, and grease repellants (Fair et al., 2010), 
and polybrominated diphenyl ethers commonly used in flame retardant (Fair et al., 2010; 
Fair et al., 2007).  Persistent organohalogen toxicants have been linked to 
immunosuppression (Mori et al., 2008), increased susceptibility to infectious diseases 
(Ross, 2002), neoplasia (Newman and Smith, 2006), endocrine disruption (Porte et al., 
2006), and reproductive impairment (Addison, 2011).   
Brucellosis is a zoonotic disease caused by Brucella ceti bacteria that has caused 
issues for marine mammal species.  Brucellosis infections have a high prevalence and are 
globally widespread amongst marine mammal species, as made evident by serological 
evidence.  Marine mammal strains of brucellosis are also capable of infecting humans 
and livestock.  Bottlenose dolphins have been noted to have Brucella placentitis and 
abortions due to infection (Miller et al., 1999). 
Lobomycosis (lacaziosis) is a chronic granulomatous disease of the skin and 
subcutaneous tissues that occurs only been documented in dolphins and humans 
(Rodríguez-Toro, 1993).  This disease is caused by a yeast-like fungus (Lacazia loboi) 
and has an expansive presence, with cases being reported in dolphins in the Surinam 
River estuary and off the coasts of North Carolina, Florida, Texas (Cowan, 1993), 
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southern Brazil (Simõse-Lopes et al., 1993), and between the Spain and French coasts 
(Symmers, 1983).  In bottlenose dolphins, aggregations of white, firm raised nodules 
were found on the edges of pectoral and dorsal fins, fluke and caudal peduncle, and the 
head.  Dolphins with lobomycosis have demonstrated severe diminishing of their 
adaptive immune response (Reif et al., 2009).   
Over the past couple of decades, the cetacean morbillivirus has emerged and 
greatly affected the population and health of many cetacean species on a global scale 
(Van Bressem et al., 2014).  This virus is highly contagious and lymphotropic (Shimizu 
et al., 2013) and has caused several mortality events in coastal T.  truncatus populations 
from the Gulf of Mexico to the Atlantic coast of the United States since 1982 (Krafft et 
al., 1995; Taubenberger et al., 1996).  Transmission of the morbillivirus is thought to 
occur after the inhalation of airborne virus shed by cetacean individuals, which is 
probable for cetaceans due to their sociable behavior and high density (Raga et al., 2008; 
Van Bressem et al., 1999).  The pathogenesis of morbillivirus infections often leads to 
immunosuppression, leading to secondary viral and bacterial infections (Appel et al., 
1982). 
The marine environment is abundant in a wide variety of pathogens, and as 
previously mentioned, immunosuppression from other infections can lead to secondary 
bacterial infections.  Previous research has found that bottlenose dolphin individuals have 
been exposed and have titers against many different common marine bacteria (Beck and 
Rice, 2003; Bossart et al., 2008; Bossart et al., 2019; Fair et al., 2017).  These bacteria 
included Erysipelothrix rhusiopathiae, Escherichia coli, Mycobacterium marinum, Vibrio 
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carchariae, Vibrio cholerae, Vibrio parahemolyticus, and Vibrio vulnificus.  Previous 
studies have reported immune responses in relative titers at a 1:200 dilution (Bossart et 
al., 2019) and antibody activity (units/µL) (Beck and Rice, 2003).  Research on marine 
pathogens has yet to include the quantification of immune responses to Streptococcus 
agalactiae in bottlenose dolphins.  Due to its global presence (Anshuman et al., 2018; 
Numberger et al., 2021), it could be a concern for bottlenose dolphins and other marine 
organisms in the future. 
 
1.3 Bottlenose Dolphins and Streptococcus agalactiae  
Streptococcus agalactiae (group B streptococcus) is a Gram-positive pathogen 
and has been of concern for terrestrial animals and farmed fishes.  In humans and cows, it 
is known to cause neonatal meningitis and mastitis, respectively (Amborski et al., 1983; 
Baker, 1997).  S. agalactiae has been observed to cause septicemia, necrotizing fasciitis, 
and large mortality events in a variety of aquatic organisms.  This bacterium has been 
known to affect crocodiles, frogs, and an array of fish species (Amborski et al., 1983; 
Bishop et al., 2007).  Both wild and farmed fishes have been affected by Streptococcus, 
some of which include menhaden (Brevo ortiapatronus), giant Queensland Grouper 
(Epinephelus lanceolatus), tilapia (Oreochromis niloticus), and mullet (Liza klunzingeri) 
(Bowater et al., 2012; Evans et al., 2002; Plumb et al., 1974).   
Due to the ability to infect both aquatic species and terrestrial mammals, it was 
thought that this bacterium could also infect marine mammals (Evans et al., 2006).  This 
was confirmed with the first known characterizations of S. agalactiae in marine mammal 
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species in the early 2000s when it was isolated from both captive and wild bottlenose 
dolphins (Evans et al., 2006; Zappulli et al., 2005).  The captive bottlenose dolphin was 
diagnosed with necrotizing fasciitis, cellulitis, and myositis due to S. agalactiae (Zappulli 
et al., 2005).  In the case of the wild dolphin, S. agalactiae was isolated from the muscle. 
However, no definitive link was made due to legal and ethical issues involved in marine 
mammal research (Evans et al., 2006).  Due to its ability to adapt and survive in a wide 
variety of environments, more events of Streptococcus agalactiae are likely to occur in 
the aquatic environment as the main route of exposure in streptococci is from the 
ingestion of streptococcal contaminated materials (Bonar and Wagner, 2003; Bromage 
and Owens, 2002).  In addition, future outbreaks in fishes could increase the transmission 
potential between species living in the same environment (Bromage and Owens, 2002).  
These outbreaks could have implications for humans and terrestrial and aquatic species as 
some studies have shown the disease associated with this pathogen may be caused by the 
same strains of S. agalactiae (Evans et al., 2008; Evans et al., 2009).   
 
1.4 Bottlenose Dolphin Immune System 
The immune system is a vital component of any organism allowing for protection 
from pathogens.  Responses to those pathogens are simple physiological reactions present 
in all living organisms (Buchmann, 2014).  The vertebrate immune system is comprised 
of innate and adaptive immune systems.  The innate immune system responds quickly, 
whereas the adaptive immune system may take days or weeks to become completely 
activated.  The adaptive immune system requires previous exposure to the antigen to have 
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a full immunological response in which cell-mediated and humoral immune responses are 
utilized (Coico and Sunshine, 2015) 
Dolphin primary and secondary lymphoid organs demonstrate similarities to those 
of other terrestrial mammals (Beineke et al., 2006).  Lymphoid tissues in bottlenose 
dolphins include the thymus, spleen, mucosal-associated lymphoid tissue (MALT), bone 
marrow, and lymph nodes (Cowan and Smith, 1999).  Some lymphoid structures are 
unique in cetaceans, such as lymphoepithelial aggregations in the larynx and anal canal 
(Beineke et al., 2010).  Primary lymphoid tissues consist of the bone marrow and the 
thymus.  The bone marrow serves as the location of hematopoiesis.  B cell maturation 
occurs in the fetal liver and switches to the bone marrow upon adulthood.  T cells 
develop initially in the bone marrow and migrate to the thymus to fully mature (Boehm et 
al., 2012).   
Secondary lymphoid tissues include the spleen, lymph node, and mucosal-
associated tissues (Stebegg et al., 2018).  These tissues are purposefully located to trap 
foreign antigens that enter the bloodstream, peripheral tissues, and mucosal sites (Randall 
and Mebius, 2014).  The spleen contains both red and white pulp regions with a marginal 
zone to facilitate the movement of cells (Cowan and Smith, 1999).  The spleen plays a 
role in the immune response to bloodborne pathogens (Haley, 2017).  The lymph nodes 
are responsible for pathogens that enter through the skin barrier or other internal surfaces 
(gut wall, lung, tonsils).  In cetaceans, the lymph nodes typically lack germinal centers 
(Romano et al., 1993).  MALT can catch and concentrate antigens which then interact 
with the lymphocytes (Coico, 2015).  They are responsible for pathogens that enter 
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through mucosal surfaces (respiratory, gastrointestinal, and urogenital tracts).  Secondary 
lymphoid tissues facilitate the interactions between dendritic cells that have met their 
antigen, B cells, and T cells to initiate the adaptive immune response (Goodnow, 1997). 
 
1.5 Bottlenose Dolphin Innate Immunity 
Innate immunity provides a nonspecific response to pathogens and is present in 
almost all animals to survive in their environment.  The innate immune system provides 
the first line of defense against pathogens and consists of physical barriers, lysozymes, 
antimicrobial peptides (AMPs), the complement system, and nonspecific leukocytes 
(Riera Romo et al., 2016; Zimmerman et al., 2010).  Physical barriers of the innate 
immune system include the skin and gut mucosa, which prevent pathogen entry into the 
organism (Riera Romo et al., 2016).  Lysozymes are antimicrobial enzymes that 
hydrolyze bacterial cell walls of both gram-negative and gram-positive bacteria resulting 
in lysis of bacteria (Callewaert and Michiels, 2010).  Lysozymes have been detected in 
the tears, nasal mucus, saliva, blood plasm, and other tissues and secretions in mammals 
(Salton, 1957).  Studies in marine mammals have used lysozyme activity as a marker of 
proinflammatory responses (Fair et al., 2017; Reif et al., 2009).  AMPs are highly 
conserved in vertebrates and have antifungal, antiviral, and antibacterial activity through 
disruption and destabilizing of microbial membranes, pore formation, inhibition of 
intracellular targets, interference in the transcription of DNA, and inhibition of protein 
synthesis and folding (Riera Romo et al., 2016; Zasloff, 2002).  Furthermore, AMPs can 
link the innate and adaptive immune response through the recruitment or activation of 
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immune cells: dendritic cells, T cells, and monocytes (Yang et al., 2000).  These peptides 
can be secreted in areas that are prone to microbial infections, such as oral mucosa, 
gastrointestinal tract, lungs, eyes, skin, and the reproductive tract (Bals, 2000). 
Other key players in innate immunity are pattern recognition receptors (PRRs) 
and Pathogen-Associated Molecular Patterns (PAMPs).  The activation of innate defense 
mechanisms is reliant on PAMPs present on invading microbes.  PAMPs are also vital to 
microbes for their survival and pathogenicity (Kumar et al., 2011).  These structures are 
expressed and conserved in many pathogens, including bacteria and fungi (Biegańska, 
2014).  To identify PAMPs, PRRs are used on cells such as macrophages, dendritic cells, 
monocytes, and endothelial cells (Blanco and Garcia, 2008).  Once the PAMPs are 
recognized by the PRR, the innate immune cell will become activated to destroy and 
clear the pathogen.  Clearance can be accomplished by phagocytosis to destroy the 
pathogen, production of various cytokines, and activation of the adaptive immune 
response through antigen presentation accompanied by cytokine stimulation (Smith et al., 
2019). 
The complement system has been identified as the first supportive line of defense 
against microbial invaders and consists of serum proteins that react against pathogens 
through a molecular cascade.  This system has three pathways that can be activated: the 
classical, alternative, and lectin pathways.  This cascade results in opsonization, enhanced 
inflammatory responses, and the formation of the membrane attack complex, ultimately 
resulting in microbial lysis (Abbas et al., 2014; Dunkelberger and Song, 2010; 
Zimmerman et al., 2010).  In mammals, the complement system comprises approximately 
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30 proteins that make up the three pathways (Smith et al., 2019).  The classical pathway 
is activated by antibody-antigen complexes and serves as a bridge between the innate and 
adaptive immune systems.  The alternative pathway is directly activated by pathogens 
and independent of antibodies.  Lastly, the lectin pathway is activated by mannose-
binding lectin residues on the pathogen surface (Coico, 2015; Smith et al., 2019).  C3 
convertase activation is induced in all three pathways, which cleaves inactive C3 into C3a 
and C3b, forming the membrane attack complex (Dunkelberger and Song, 2010).   
Acute-phase proteins (APP) are involved in the acute-phase response (APR), 
which is induced by infection, trauma, or inflammation to the host (Johnson, 1997).  This 
response is induced by proteins called cytokines which act as messengers between the 
local injury site and the hepatocytes that make APPs.  Studies in bottlenose dolphins have 
utilized APPs as indicators of baseline health and to further understand immune 
responses in these organisms (Goldstein et al., 2006).  In mammals, the main APPs are C-
reactive protein (CRP), serum amyloid A and P, a2-macroglobulin, fibrinogen, and 
transferrin, amongst a few others (Cray et al., 2009).  The majority of research has been 
conducted on CRP.  CRP is a highly conserved serum protein (Sproston and Ashworth, 
2018).  During injury, infection, and inflammation, CRP levels increase dramatically in 
response to the damage or pathogen entry (Sproston and Ashworth, 2018).  CRP is 
important for protection and defense from bacteria and aids in the induction of apoptosis 
(Sproston and Ashworth, 2018). 
Major cell types that play a role in innate immunity are phagocytes (monocytes, 
macrophages, neutrophils, and dendritic cells), natural killer cells, epithelial cells, and 
 12 
endothelial cells (Chaplin, 2010).  Neutrophils, monocytes, and macrophages 
phagocytose pathogens and particles that have been tagged to be cleared by binding Ig or 
complement.  These phagocytic cells release cytokines and serve as antigen-presenting 
cells (APCs), which present antigens to T cells connecting the innate and adaptive 
immune responses (Coico and Sunshine, 2015).  Neutrophils are considered the main 
effector cell of the innate immune response and are the first cell type to respond to the 
site of infection (Kaiser, 2010).  Natural killer cells (NK cells) assist in killing virally 
infected cells and cause the infected cell to undergo apoptosis (Vivier et al., 2011).   
Epithelial and endothelial cells express PRRs on their cell surface to recognize PAMPs 
from pathogens to secrete proinflammatory cytokines and release antimicrobial peptides 
(Nakanaga et al., 2007) 
 
1.6 Bottlenose Dolphin Adaptive Immunity 
Depending on the route of immune response induction, adaptive immunity can be 
further divided into cell-mediated or humoral immunity.  The adaptive immune response 
has great specificity for target antigens (Yuan et al., 2014).  These responses are based on 
the antigen-specific receptors on the surfaces of B- and T-lymphocytes (Chaplin, 2010).  
The cell-mediated immune system is centered on restricted antigen presentation to the T 
cell receptor (TCR) on T cells via the major histocompatibility complex (MHC), which 
assists the T cell in differentiating the self-component and microbial structures (Chaplin, 
2010; Yuan et al., 2014).  T cells play a role in antibody regulation but do not produce 
antibodies (Zimmerman et al., 2010).  T cells are important in the identification and 
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destruction of infected host cells (Chaplin, 2010).  The humoral immune system is 
mediated by the secretion of immunoglobulins (Igs) by B cells.  B cells can recognize 
pathogens and can secrete highly specific antibodies to that pathogen when bound to an 
antigen. 
Mammals produce five different classes of Igs: IgM, IgD, IgA, IgG, and IgE.  Igs 
are formed by the combination of two identical heavy chains and two identical light 
chains held together by disulfide bonds.  The heavy and light chains contain a constant 
region and variable region.  The variable region of the heavy and light chains forms the 
antigen binding site (Nicholson, 2016; Zimmerman et al., 2010).  The Ig heavy chain and 
T cell repertoire are generated by variable, diversity, and joining (VDJ) recombination 
events (Yuan et al., 2014).  The light chain is formed through V and D gene 
rearrangement.  This process provides a great deal of diversity amongst receptors and Igs 
(Collins and Watson, 2018).  IgM is found in all jawed vertebrates, produced in response 
to gram-negative bacteria, and is very effective at activating complement (Coico, 2015).  
Before a B cell meets an antigen, IgD is co-expressed on the cell surface with IgM and 
serves as a transmembrane antigen receptor (Chen and Cerutti, 2011).   
IgA in mammals is found in saliva, mucus, and gastric fluid secretions, which help 
protect against respiratory and gastrointestinal infections.  IgG is the major antibody that 
aids in protectiion and immunity against bacterial or viral infections from a secondary 
immune response (Zimmerman et al., 2010).  Lastly, IgE serves as the first line of 
defense against parasites and mediates allergic reactions that include systemic and 
localized anaphylaxis (Burton and Oettgen, 2011; Wu and Zarrin, 2014).   
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1.7 Role as Sentinel Species 
Marine sentinel species provide a way to evaluate the aquatic ecosystem's health.  
Utilizing marine organisms provides early warnings about current or potential negative 
impacts on animal health on the individual and population level.  These warnings allow 
for the characterization and management of potential oceanic impacts that would affect 
human and organismal health (Bossart, 2011).  Bottlenose dolphins have inshore (coastal 
and estuarine) and offshore populations allowing the data collected to compare these 
geographical locations.  Inshore populations are often near and around areas with human 
activities and anthropogenic pollutants (Reif et al., 2015; Wells et al., 2004).  Bottlenose 
dolphins can serve as great sentinel species due to their long life spans, long-term coastal 
residencies, occupation of a high trophic level, and large blubber stores that can serve as 
sinks for anthropogenic toxicants (Bossart, 2011; Moore, 2008; Wells et al., 2004).  This 
can result in biomagnification, and often toxicants are found in high concentrations in 
these organisms.  In addition, marine mammals are sociable, charismatic megafauna that 
stimulate a positive response in humans making humans more likely to be attentive to 
ocean health matters (Bossart, 2011).  Lastly, these organisms have been subject to health 
assessments over the past decades that included behavioral, physiological, 
immunological, and biochemical analyses that have provided a great deal of information 
about their current health and past health (Adams et al., 2014; Beck and Rice, 2003; Fair 
et al., 2010; Fair et al., 2017; Piwetz, 2019).  With this information, scientists can gain an 
understanding of environmental and bottlenose dolphin population health. 
1.8 Specific Aims  
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To date, two Streptococcus agalactiae events have been identified in bottlenose 
dolphins; one in captivity (Zappulli et al., 2005) and one free-ranging (Evans et al., 
2006).  This bacteria's ability to survive and adapt in a wide range of environments and 
hosts could pose a significant issue for bottlenose dolphins, the environment, and human 
health (Anshuman et al., 2018; Evans et al., 2008).  Much progress in the understanding 
of S. agalactiae has been made in humans.  However, there is still much to learn about 
the immune response in bottlenose dolphins and the epidemiology of this bacterium.  To 
further understand S. agalactiae and its impact on bottlenose dolphin populations, this 
study plans to investigate managed-care dolphins and wild common bottlenose dolphin 
populations along the east and southeast coast of the United States.  Bottlenose dolphin 
serum samples will be used to quantify serum titers and antibody activities against S. 
agalactiae.  If a main protein(s) that these dolphins are recognizing can be identified, 
proteomics can be carried out to provide further insight into the dominant proteins 
involved in the immune response to this pathogen.  A dominant protein could serve 
useful in generating a vaccine against S. agalactiae.   
 
Aim 1: Investigate differences between relative titers and antibody activity utilizing 
bottlenose dolphin (Tursiops truncatus), Bull Shark (Carcharhinus leucas), Spotted 
Eagle Rays (Aetobatus narinari), and Loggerhead Sea Turtles (Caretta caretta) 
antibody responses to Streptococcus agalactiae through the generation of 
monoclonal antibodies against primary immunoglobulins.   
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Aim1a: Bottlenose dolphin serum samples have been provided by NOAA, the  
Georgia Aquarium, and United States Navy from dolphins along the east and 
southeastern seaboard of the United States and dolphins in managed human care.  Bull 
Sharks and Spotted Eagle Rays plasma samples were collected from organisms as part of 
a fishery-independent survey in the Indian River Lagoon.  Serum and plasma samples 
from these marine vertebrates will be used along with a protein A/G column to purify 
IgG or IgM.  The purity of the Ig sample will be verified via SDS-PAGE.   
 
Aim1b: Monoclonal antibodies against the heavy chain domain of IgG or IgM will be 
generated using pure Ig, balb/c mice, and previously established immunization methods 
from the Rice lab.  Single-cell suspensions from the spleens of sacrificed mice will be 
fused with myeloma cells resulting in hybridomas that will be cultured, screened, and 
cloned.  Supernatants from the hybridomas will then be used as the source of monoclonal 
antibodies.   
 
Aim1c: The monoclonal antibodies will be validated using Western blot analysis.  Serum 
samples will be diluted and subjected to SDS-PAGE.  The gel will then be transferred, 
blocked, and probed with the generated monoclonal antibody and anti-mouse IgG -
Alkaline phosphatase buffer.  The blot will be developed to determine the validity of the 
monoclonal antibody.   
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Aim 1d: Develop an ELISA to quantify titers and antibody activities against S. agalactiae 
using developed monoclonal antibodies.   
 
Aim1e: Compare relative titers and antibody activities in bottlenose dolphins, spotted 
eagle rays, bull sharks, and loggerhead sea turtles.   
 
Aim 2: Determine the dominant proteins involved in the immune response against S. 
agalactiae in bottlenose dolphins.   
Aim2a: Create an S. agalactiae lysate sample using freeze-thaw methods or sonication 
that will be used in the immunoprecipitation (IP) assay. 
  
Aim2b: Immunoprecipitation assay will be performed with pooled bottlenose dolphin 
serum to generate a pure IgG sample bound to the agarose beads followed by the sample 
of bacteria lysate.  Samples of the lysate before IP, the washes, after IP, and elutions will 
be collected.   
 
Aim2c: Visualize and identify dominant proteins involved in the immune response 
utilizing SDS-page with Coomassie blue staining and Western blot analysis.   
 
Aim 3: Determine bottlenose dolphin serum Ab titers against Streptococcus 
agalactiae utilizing enzyme-linked immunosorbent assays (ELISAs) and compare 
these activities to antibody titers in four different populations; Charleston Harbor, 
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Indian River Lagoon, Georgia Aquarium, and the United States Navy Marine 
Mammal Program. 
Aim3a: By developing an ELISA to quantify titers using a generated monoclonal 
antibody against bottlenose dolphin IgG, activities of antibodies can be compared to 
titers.   
 
Aim3b: ELISA data will be used to compare relative titers to antibody activities.  
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Mouse monoclonal antibodies (mAbs) were generated against bottlenose dolphin, 
Tursiops truncatus, IgG, bull shark, Carcharhinus leucas and spotted eagle ray, 
Aetobatus narinari, IgM.  Along with a previously generated mAb against loggerhead, 
Caretta caretta, IgY, these biological reagents were used to compare the sensitivity of 
relative antibody titers at sample dilutions of 1:200 in buffer to calculated antibody 
activities across multiple serial dilutions against Streptococcus agalactiae.  Global 
Streptococcus agalactiae and related pathogen infections are increasing and place both 
humans and environmental species at risk. Notably, Streptococcus agalactiae is now 
considered to be an emerging and zoonotic pathogen.  Robust antibody responses were 
observed in each species, though some individuals differed significantly depending on 
whether viewed as relative antibody titers or antibody activities.  The data from this study 
indicate that calculated antibody activities are more sensitive than relative antibody titers 
in determining antibody responses despite being much more labor-intensive, expensive, 
and time consuming.  This study provides several novel antibody reagents to the greater 
animal health community, with a particular application to monitoring sentinel species for 
exposure to new emerging and zoonotic pathogens within the context of Oceans and 





The human population living along coastal habitats has increased greatly over the 
last several decades.  Along with this increase, so too has the impact of humans on 
delicate marine and estuarine habitats. Reciprocally the human population is impacted as 
well.  This reality has led to the formation of a global community of scientists and 
decision-makers to engage the Oceans and Human Health (OHH) program (Bowen et al., 
2006; Fleming et al., 2006; Fleming et al., 2014; Laws et al., 2008; McGowan et al., 
2016).  The collective OHH community links the effects of increased human fecal waste 
discharge, increasing eutrophication due to nutrient run-off, zones of low oxygen, noise 
pollution, plastic contamination, over-harvesting, rising global temperatures, and others 
(Bowen and Depledge, 2006; Kemp et al., 2005; Knap et al., 2002; Koelmans et al., 
2014).  Collectively, these factors impart significant stress to estuaries and nearby coastal 
ecosystems.  Moreover, these environmental stressors also include the likelihood of 
humans coming into contact with aquatic pathogens associated with known and emerging 
environmental pathogens (Shuval, 2003).  For example, several human zoonotic 
pathogens, such as Vibrio cholera, Vibrio vulnificus, and Vibrio parahaemolyticus, are 
part of the indigenous microbial community.  However, in immunocompromised humans, 
these bacteria and other potential pathogens can cause significant disease.  An overview 
of the interactions between humans and aquatic pathogens from an OHH perspective has 
been extensively reviewed (Bienfang et al., 2011; Dyble et al., 2008). 
 One of the key factors in understanding and possibly managing the pathogenic 
component of OHH is monitoring the presence of various pathogens (Stewart et al., 
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2008).  Monitoring the prevalence and extent of these outbreaks is easily done by PCR 
using water, soil, or tissue samples (Ahmed et al., 2008; Li et al., 2020; Loge et al., 
2002).  However, this information may not reveal the potential for infectivity, 
transmission, or immunological response (Stewart et al., 2008).  Another key component 
of monitoring for environmental pathogens is identifying a sentinel species, and to this 
end, bivalves have routinely served this purpose because of sediment exposures and high 
rate of water column filtration (Kueh and Chan, 1985).  A major drawback of using 
sedentary sentinels to monitor for environmental pathogen prevalence is that some 
zoonotic or emerging pathogens could be associated with large or highly mobile animals 
such as bony fish, elasmobranchs, sea turtles, and marine mammals.  Pathogens 
associated with these aquatic vertebrates may be missed in routine monitoring using 
bivalves or rapid PCR approaches. 
 Determining seropositivity and quantifying antibody responses to various 
pathogens of interest in humans is routine but is an under-appreciated and under-utilized 
tool in environmental monitoring programs.  This approach is limited to only a few 
organisms due to a lack of species-specific antibody reagents.  Also, the type of antibody 
responses in lower versus higher vertebrates is different in kinetics and antibody 
(immunoglobulin; Ig) class (Smith et al., 2019; Sun et al., 2020).  Bony fish and 
elasmobranchs secrete IgM primarily in response to an immunogen, though other Ig 
classes are generated as well.  One of the most essential functions of IgM is to activate 
complement.  Serum IgM also contains natural antibodies against various carbohydrates, 
glycosylated proteins, and pathogen-associated molecular patterns, leading to a high 
 32 
degree of cross-reactivity.  In addition to IgM, reptiles such as sea turtles also secrete IgY 
as their mature antibody response to environmental pathogens (Rodgers and Rice, 2018; 
Rodgers et al., 2018).  Marine mammals, like humans, generate and secrete IgG as the 
mature Ig response to pathogens (Beck and Rice, 2003; Nollens et al., 2007; Nollens et 
al., 2008).  Once species-specific antibodies are available, one can develop ELISA assays 
to monitor antibody responses in a variety of aquatic vertebrates. 
 The most common method for quantifying antibody responses to pathogens in 
aquatic animals of interest is by determining titers, often expressed as the reciprocal of 
the lowest sample dilution yielding the highest optical density.  Our lab has typically used 
1:200 dilutions in buffer, and the associated optical density is multiplied by 200 to yield a 
relative titer (Beck and Rice, 2003; Fair et al., 2017; Karsten and Rice, 2006; Rodgers et 
al., 2018).  Though seldom employed because of the intense labor and supply exhaustion, 
one can also quantify the activities of antibodies generated in response to pathogens 
(Arkoosh and Kaatari, 1990).  While antibody titers reveal the relative amount of specific 
antibodies in a sample, this information alone does not indicate the affinity or quality of 
the antibody.  Furthermore, circulating antibody titers will diminish over time once the 
specific pathogen is cleared from the animal, but the affinity of the antibody in 
circulation may be higher over time.  By comparing antibody titers to antibody activities 
in a biological sample, one may inquire more information than simple seropositivity for 
exposure to environmental pathogens.  In this study, we developed monoclonal 
antibodies (mAbs) against bottlenose dolphin (Tursiops truncatus) IgG, bull shark 
(Carcharhinus leucas) and spotted eagle ray (Aetobatus narinari) IgM, and used a 
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previously described mAb against loggerhead sea turtles (Caretta caretta) IgY (Rodgers 
and Rice, 2018) to compare titers and activities against an aquatic strain of Streptococcus 
agalactiae, an emerging environmental pathogen (Evans et al., 2008; Evans et al., 2009; 
Numberger et al., 2021).  We also discuss the features and benefits of each approach.  
This study also provides additional mAbs to the scientific community for future work in 
these iconic and gregarious marine vertebrates. 
 
2.2 Materials and Methods  
 
2.2.1 Animals 
Bull Sharks and Spotted Eagle Rays were captured as part of a fishery-
independent survey in the Indian River Lagoon (IRL) between Brevard and Martin 
Counties of Florida between 2017 and 2019 (Roskar et al., 2020).  Sampling was 
conducted each season (winter = January–March; spring = April–June; summer = July–
September; fall = October–December) using a bottom longline and a monofilament 
gillnet. Captured elasmobranchs were identified to species level, and a blood sample 
(<1% of body weight) was collected from each individual via a caudal vein or wing vein 
(rays) puncture with an 18 or 20 gauge 1-1.5-inch needle connected to a 10 ml syringe 
and immediately transferred to one heparinized sodium tube and one serum separator 
tube.  Animals were released back into the lagoon and were observed free-swimming 
post-release when possible. Blood samples were centrifuged for 10 minutes at 4500 rpm. 
Separated serum and plasma were then transferred to cryovials and stored at -80°C before 
shipping.  Handling and sampling were conducted under protocols approved by the 
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Florida Atlantic University Institutional Animal Use and Care Committee (FAU 
AUP#16-16, 19-27).  Bottlenose dolphin serum samples were randomly chosen from 
those stored and used in previous studies involving IRL dolphins and sent to Clemson 
University for previous immunological assays (Beck and Rice, 2003; Bossart et al., 2008; 
Bossart et al., 2011; Bossart et al., 2019; Fair et al., 2013; Fair et al., 2017).  An in-hand 
monoclonal antibody (mAb LH-9) against loggerhead sea turtle IgY has been previously 
described with technical applications (Rodgers and Rice, 2018).  Serum samples from 
loggerhead turtles were collected in the summer of 2019 during routine monitoring 
efforts by the South Carolina Department of Natural Resources and the Southern Atlantic 
Fish Management Council and shipped overnight to Clemson University under NOAA 
Section 10 (A) (1) (a) permits 15566 and 19621. 
 
2.2.2.  Immunoglobulins M and G purifications and monoclonal antibody production 
An on-hand monoclonal antibody (mAb LH-9) against loggerhead sea turtle IgY 
has been previously described with technical applications (Rodgers and Rice, 2018).  
Immunoglobulin M (IgM) was purified from bull shark and spotted eagle ray serum 
samples using Protein-A columns as previously described for the Atlantic sharpnose 
shark, Rhizoprionodon terraenovae, (Karsten and Rice, 2006).  This approach was 
previously shown to be efficient for isolation of IgM from several fish species, including 
elasmobranchs (Bromage et al., 2004; Karsten and Rice, 2006; Shin et al., 2006).  In 
brief, plasma samples from several bull sharks and spotted eagle rays were pooled by 
species and centrifuged for 10 min at 500 × g to separate precipitated proteins. The 
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overlying serum was diluted 1:1 with 10 mM Tris–HCl, pH 8, and applied to a column of 
immobilized Protein-A (Pierce, Rockford IL USA) previously equilibrated with the same 
buffer.  Purified IgM was eluted in 1 ml fractions from the column with 0.1 M glycine 
buffer, pH 2, and subsequently adjusted to a pH of 7.6 with 100 µL 1 M Tris–HCl, pH 8.  
Protein-A-purified IgM from each species was subjected to 4-20 % SDS-PAGE and 
subsequent Coomassie-blue staining to check for relative purity of the product. 
 Due to the loss of previously generated hybridomas secreting mAbs against 
bottlenose dolphin IgG (Beck and Rice, 2003), it was necessary to generate another 
source.  Immunoglobulin G (IgG) was purified from bottlenose dolphin serum samples 
using Protein-G columns as previously described (Beck and Rice, 2003).  In brief, serum 
samples were pooled and centrifuged for 10 min at 500 ×g to separate precipitated 
proteins. The overlying serum was diluted 1:1 with 10 mM Tris–HCl, pH 8, and applied 
to a column of immobilized Protein-G column previously equilibrated with the same 
buffer.  Purified IgG was eluted from the column in 1 ml fractions with 0.1 M glycine 
buffer, pH 2, and subsequently adjusted to a pH of 7.6 with 100 µL 1 M Tris–HCl, pH 8.  
Protein-G-purified IgG was subjected to 4-20% SDS-PAGE and subsequent Coomassie-
blue staining to check for relative purity of the product. 
Six-week-old female Balb/c mice were housed at the Godley-Snell Animal 
Facility at Clemson University under IACUC approved animal use protocols. Mice were 
given a sub-cutaneous (s.c.) injection of 50 µg purified bull shark IgM, spotted eagle ray 
IgM, or bottlenose dolphin IgG in 0.9% saline containing TiterMax Gold adjuvant on day 
1. Two weeks later, mice received a second s.c. immunization using Freund’s incomplete 
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adjuvant.  Subsequent boosters at 21-day intervals were given in saline via s.c. 
immunizations, and the final booster was given by intraperitoneal injection.  Five days 
after the last booster immunization, mice were sacrificed using slow lethal CO2 hypoxia, 
and their spleens removed using aseptic methods.  Procedures for splenic plasma cell 
fusion with Sp02-14 myelomas and for screening, cloning, purification, and isotyping of 
the resulting monoclonal antibodies (mAb) have been described elsewhere (Margiotta et 
al., 2017; Rice et al., 1998).  Subsequent testing revealed that mAbs 4F8, SER12-9, and 
KA-6 were most suitable for bull shark IgM, spotted eagle ray IgM, and bottlenose 
dolphin IgG, respectively.  Each of these three mAbs were found to be an IgG1 κ isotype. 
 Whole sera from each species were then diluted and subjected to SDS-PAGE and 
immunoblotting to verify specificity against targeted proteins of interest.  Whole serum 
samples and purified Igs were diluted and loaded into a 4-20% MiniPROTEAN® TGX 
Stain-FreeTM Protein Gel (BioRad) and subjected to SDS-PAGE as previously described 
above.  A BLUelf Prestained Protein molecular weight marker (FroggaBio) was used to 
serve as a reference.  The proteins on the gel were then transferred to an Immun-Blot® 
PVDF membrane at 100V for one hour at 4oC.  After the transfer, blots were blocked for 
16 hours with 10% fetal calf serum in 0.01M PBS at 4°C.  The blots were then probed 
with their respective mAbs for 1.5 hours: KA-6 against bottlenose dolphin IgG, 4F8 
against bull shark IgM, or SER12-9 against spotted eagle ray IgM. The incubation was 
followed by three 5-minute washes with 0.05% PBST.  Lastly, blots were incubated in 
anti-mouse IgG-Alkaline phosphatase buffer (AP) (1:1,000 in PBS; Thermo-Fisher), for 
one hour and following the same wash procedure as before.  The blot was developed with 
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5-bromo-4-chloro-3'-indolyphosphate p-toluidine salt (BCIP) and nitro-blue tetrazolium 
chloride (NBT) in AP buffer, allowing the AP activity to be visualized and recorded.   
An in-hand monoclonal antibody (mAb LH-9) against loggerhead sea turtle IgY 
has been previously described with technical applications (Rodgers and Rice, 2018).  
Serum samples from loggerhead turtles were collected in the summer of 2019 during 
routine monitoring efforts by the South Carolina Department of Natural Resources and 
the Southern Atlantic Fish Management Council and shipped overnight to Clemson 
University under NOAA Section 10 (A) (1) (a) permits 15566 and 19621. 
 
2.2.3 Development of enzyme-linked immunosorbent assays (ELISAs) 
Streptococcus agalactiae cultures from an aquatic strain were a generous gift 
from Dr. John Hawke, Louisiana State University, and grown as directed (Soto et al., 
2015).  High bonding 96 well plates (Corning, #9018) were coated for 16 h at 4° C with 
75 µL of a 0.1 mg/mL solution of poly-D-lysine in distilled water, followed by wash 
steps with 0.05% PBS Tween 20 (PBST).  To perform the ELISAs, S. agalactiae was 
again grown at approximately 33ºC for 24 hours in tryptic soy broth media.  The bacteria 
suspension was then spun down at 2500 rpm for 15 minutes.  The supernatant was 
removed, and the pellet was resuspended in 20 mL of 0.01M phosphate-buffered saline 
(PBS).  This procedure was repeated two more times, but the pellet was resuspended in 
10 mL of PBS following the last centrifugation.  To determine the optical density, 100 μL 
of the S. agalactiae was placed in duplicate in the wells of a 96 well plate and recorded at 
600 nm.  The bacterial suspension was then diluted to the established optical density of 
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0.200 for S. agalactiae.  Optimized suspensions of live bacterium were then prepared, 
and 75 µL of the bacteria were added to wells of the 96 well plates using our lab’s 
modifications (Beck and Rice, 2003; Karsten and Rice, 2006; Rodgers et al., 2018) of the 
original developers of the assay (Waterstrat et al., 1991).  The plates were centrifuged at 
2500 rpm for 5 minutes and then incubated at room temperature for 15 minutes.  
Following the 15-minute incubation, the plates were washed twice in PBS, and 100 μL of 
glycine-BSA (100 mM glycine with 1% BSA) was added to the plates to then incubate at 
room temperature for 30 minutes.  The plates were washed in PBS two times and let dry 
at room temperature.   
The dried plates each received 100 μL of 5% BSA blocking buffer, which 
incubated for one hour at room temperature.  Serum suspensions were made by adding 10 
µL of plasma from each individual animal into 990 µL of PBS in 1.5 mL snap cap tubes 
to yield a 1:100 dilution.  As a reference sample for calculating relative titers, a 
composite sample for each species comprised of serum or plasma from randomly selected 
individuals in PBS was made at a 1:100 dilution.  To each plate, 150 μL of each serum 
suspension and pooled standard sample were added in duplicate so that each plate could 
have five samples and a standard curve. Samples were serially diluted with 75 μL of PBS 
to yield 1:100, 1:200, 1:400, 1:800, 1:1600, and 1:3200 dilutions and incubated at 4º C 
overnight (Figure 2.1).  Each plate contained two wells of the composite serum sample to 
serve as a reference for any possible plate-to-plate variation, and two wells per plate 
received 75 µL PBS as an assay control.  The next day, plates were washed three times 
with 0.05% PBST, and then 75 µL of diluted mAb were added to respective wells.  Plates 
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were washed three times with 0.05% PBST after 2 hours of room temperature incubation.  
Goat anti-mouse IgG AP (1:1500) was added in 75 µL volumes to each well and 
incubated at room temperature for one and half hours before being washed five times 
with PBST.  Finally, 75 µL of 1 mg/mL p-nitrophenol phosphate (ThermoFisher) in AP 
buffer were added to each well. The plates were incubated for 30 min at room 
temperature enzymatic reaction was stopped with 100 µL 2M NaOH.  Optical densities 
for all plates were read at 405 nm and the data recorded. 
 
Figure 2.1. Experimental setup for ELISA.  The experimental setup shown allowed for 
five serum samples (S) starting at a dilution of 1:100, a standard (STD) curve created 
from pooled serum, and four wells without serum for controls; primary antibody (1o) and 




2.2.4.  Determining relative titers vs. antibody activity levels 
Relative antibody titers were calculated as the optical density (OD) multiplied by 
the serum dilution factor of 1:200 (Bossart et al., 2008; Fair et al., 2017; Karsten and 
Rice, 2006; Rodgers et al., 2018).  Antibody activity for each sample was determined 
using previously published methods (Arkoosh and Kaatari, 1990) and expressed as units 
of activity per µL serum.  In brief, dilutions were expressed as the equivalent volume of 
the undiluted serum determined by taking the product of the volume of dilution used (75 
µL) and each of the dilution factors. The standard curve was then used to determine the 
volume of serum at the 50% point of the maximum O.D. obtained for the standard pooled 




) . Each sample was plotted against the 50% point of the 
maximum O.D. from the standard curve to determine the volume of test sample at that 
50% point of the standard. To determine the activity for each of the test samples, the 
following equation was used:   
 𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑜𝑓 𝑇𝑒𝑠𝑡 𝑆𝑎𝑚𝑝𝑙𝑒 =  (𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑜𝑓 𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑)  × (
50% 𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑
50% 𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑇𝑒𝑠𝑡 𝑆𝑎𝑚𝑝𝑙𝑒
) 
 
2.2.5.  Statistical analysis 
Antibody titers from each species at 1:200 dilutions were compared to their 
calculated activities using a Mann-Whitney U test.  Correlations between individual 
relative titers at 1:200 dilutions and the same individual’s antibody activity were 
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determined by Pearson’s correlation coefficient using GraphPad Prism9’s statistical 
software.  The α-value was set at 0.05 prior to the study. 
 
2.3 Results and Discussion 
In this study, we first purified bottlenose dolphin IgG using previously described 
techniques involving protein G columns (Beck and Rice, 2003), and purified IgM from 
bull shark and spotted eagle rays using purified using protein A columns, also as 
demonstrated in previous work (Karsten and Rice, 2006).  Other methods to purify IgM 
were attempted as well, including a Pierce IgM purification kit (product # 44897) that 
capitalizes upon the ability of IgM to bind mannose-binding lectin immobilized on 4% 
beaded agarose, and by a stepwise dextran sulfate/CaCl2 and NH4SO4 precipitation 
approaches to produce a crude IgM batch (dos Santos et al., 1997).  Neither of these 
methods produced purified IgM to the level of the protein A method.  Under reducing 
conditions, purified bottlenose IgG consists of the expected ≈ 55 kDa heavy chains and ≈ 
25 kDa light chains (Figure 2.2A).  Under similar conditions, purified spotted eagle ray 
and bull shark IgM consists of the expected ≈ 78 kDa heavy chains and ≈ 27 kDa light 
chains (Figure 2.2B and Figure 2.2C).  Attempts to generated mAb against these 
immunoglobulins were successful in that mAb KA-6 is specific for the heavy chain of 
bottle nose dolphin IgG, and mAb SER12-9 and mAb 4F8 are specific to the light chains 
of spotted eagle ray and bull shark IgM, respectively.  There were no attempts to 
determine cross-reactivity between the two mAbs against elasmobranch light chains, but 
based on previous studies with loggerhead sea turtles we show that mAb LH-9, which is 
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specific for the light chains of IgY, does react with all sea turtles tested (Rodgers and 
Rice, 2018).  It is possible that our mAbs may recognize IgM in other elasmobranch 
species.  
Figure 2.2.  SDS-PAGE with Coomassie blue staining and Western blot analysis of 
purified immunoglobulins. (A) SDS-PAGE and Coomassie blue staining of purified 
bottlenose dolphin IgG products, followed by Western blotting with mAb KA-6.  Lane 1: 
molecular weight marker; Lane 2: purified IgG; lane 3; molecular weight standard; lane 4 
immunoblot results showing recognition of 55 kDa heavy chain.  (B) SDS-PAGE and 
Coomassie blue staining of purified IgM products, followed by Western blotting with 
mAb SER 12-9.  Lane 1: molecular weight marker; Lane 2: purified IgG; lane 3; 
molecular weight standard; lane 4 immunoblot results showing recognition of 27 kDa 
light chain.  (C) SDS-PAGE and Coomassie blue staining of purified bull shark IgM 
products, followed by Western blotting with mAb 4F8.  Lane 1: molecular weight 
marker; Lane 2: purified IgG; lane 3; molecular weight standard; lane 4 immunoblot 
results showing recognition of 27 kDa light chain. 
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Streptococcus agalactiae (group B streptococcus) is a Gram-positive bacterial 
pathogen known to cause septicemia, necrotizing fasciitis, and large mortality events in a 
variety of aquatic organisms.  For example, this bacterium is known to affect crocodiles, 
frogs, and an array of bony fish species (Amborski et al., 1983; Bishop et al., 2007; 
Bowater et al., 2012; Evans et al., 2002; Plumb et al., 1974; Soto et al., 2015) and 
elasmobranchs (Bowater et al., 2018; Morick et al., 2020).  In humans and bovines, it is 
known to cause neonatal meningitis and mastitis, respectively (Amborski et al., 1983; 
Baker, 1997).   
Streptococcus agalactiae has also been isolated from both captive and wild 
bottlenose dolphins (Evans et al., 2006; Zappulli et al., 2005).  For further information on 
Streptococcal sp infections in marine mammals, a thorough overview is available in a 
recent review (Numberger et al., 2021).  Due to its ability to adapt and survive in a wide 
variety of environments, more outbreaks of Streptococcus agalactiae are likely to occur 
in the aquatic environment as the main route of exposure is from the ingestion of 
streptococcal contaminated materials (Bonar and Wagner, 2003; Bromage and Owens, 
2002; Numberger et al., 2021). In addition, future outbreaks could have implications for 
humans and aquatic species as some studies suggest that disease associated with this 
pathogen may be caused by the same or similar strains of S. agalactiae (Evans et al., 
2008; Evans et al., 2009; Numberger et al., 2021; Soto et al., 2015).  To our knowledge, 
there are no previously published studies describing antibody responses against S. 
agalactiae in bottlenose dolphins, spotted eagle rays, and bull sharks collected from wild 
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and free-ranging animals.  Our lab has examined antibody responses quantified as 
relative titers against S. agalactiae in loggerhead and Kemp’s ridley turtles using general 
mouse polyclonal anti-sera against IgY (Rodgers et al., 2018). However, we have not 
examined antibody responses using specific monoclonal antibodies against sea turtle IgY. 
Whole S. agalactiae lysates under reducing conditions were probed with plasma 
or serum from each species of study herein and were shown to have several proteins of 
varying sizes recognized by pooled serum samples after probing again with species-
specific mAbs (Figure 2.3).  Loggerhead sea turtles also recognize several proteins in 
similar lysates as determined previously using mouse polyclonal anti-sera against IgY 
(Rodgers et al., 2018).  Immuno-reactivity was specific to the mAbs because no bacterial 






Figure 2.3.  Western blot analysis demonstrating bottlenose dolphin, spotted eagle 
ray, and bull shark whole serum activity against S. agalactiae lysate using (A) mAb 
KA-6, (B) mAb SER-19, and (C) mAb 4F8, and PBS (D).  Lane one for each Western 
blot contains the protein molecular weight marker; Lane 2 of each blot contains whole S. 
agalactiae lysate probed with whole serum diluted 1:100 for each organism followed by 
the appropriate mAbs and polyclonal secondary antibody. 
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When comparing how relative antibody titers and antibody activities are 
calculated, it is generally expected that titers would be statistically higher than activities, 
and this was the case except for spotted eagle ray samples (Figure 2.4).  In general, 
relative titers are tightly clustered in bottlenose dolphin, loggerhead, and bull shark 
samples. In contrast, in spotted eagle ray samples, half had very low titers while the other 
half were roughly 10 times higher.  Interpreting the significance of this is difficult 
because the sample size is very small, which is due to the sparse distribution of these 
animals during field work.  These data may suggest that some animals have not been 
exposed to S. agalactiae or that circulating spotted eagle ray IgM is not as cross-reactive 
with similar antigens.  As noted, antibody titers in bull sharks are tightly clustered even 
though the sample size is similar to what was available for spotted eagle rays.  In this 
case, it is probable that all bull sharks sampled were previously exposed to S. agalactiae 
or that their IgM is cross-reactive with similar antigens. 
Antibody activity data were less clustered than relative titers.  This variability is 
related to varying optical density values between samples as they are serially diluted, and 
thus some and some samples had higher signal levels at higher dilutions.  In this view, it 
appears that antibody activity data is more sensitive than relative titers in determining 
differences between samples.  The highest available sample size (n=35) was for 
bottlenose dolphins, and thus a large distribution of activities, ranging from 1.7 to 36 
Units per μl sample (Figure 2.4A).  Activities in loggerhead samples ranged between 1.8 
and 11.36 (Figure 2.4B), between 5.7 and 57 for spotted eagle ray samples (Figure 
2.4C), and between 2 and 12.5 for bull shark samples (Figure 2.4D).  Of particular note, 
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half of the relative titer data for spotted eagle ray samples were high and the other half 




































































































Figure 2.4.  Comparison of relative antibody titers of serum or plasma dilutions at 
1:200 and antibody activities (U/µl) for (A) bottlenose dolphins, (B) loggerhead sea 
turtles, (C) spotted eagle rays, (D) and bull sharks. Significant differences between the 
mean relative titer and mean activities were found for bottlenose dolphins (A), 
loggerhead turtle (B), and bull shark (D). Spotted eagle relative titers and antibody 
activities did not differ (C). *** denotes p < 0.001; **** denotes p < 0.0001. 
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One of the key questions from this study is whether antibody titers predict 
antibody activity in environmental species.  This is important because calculating 
antibody activities is much more labor-intensive, requires significantly more research 
consumables, and is far more time-consuming.  Of the four species examined in this 
study, only bull shark antibody activities correlated with relative titers (Figure 2.5).  If 
the sample size were larger for spotted eagle rays and loggerhead turtles, there might be a 
better correlation.  At this point, the discrepancy between relative titers and activities in 
spotted eagle ray samples is unclear. However, as mentioned previously, it may be 
associated with cross-reactivity of serum samples with similar antigens on other marine 


























































































































r = 0.9179, p < 0.004 ***
n = 10 pairs
 
Figure 2.5.  Spearman correlation analysis between relative titers of serum or 
plasma dilutions at 1:200 to antibody activities (U/μl) in (A) bottlenose dolphins, (B) 
loggerhead sea turtle, (C) spotted eagle rays, (D) and bull sharks. No significant 
correlations were found for relative antibody titers and antibody activities in bottlenose 
dolphins, loggerhead sea turtles, and spotted eagle rays. There was a positive correlation 




In summary, we have generated novel monoclonal antibodies that are now 
available to the larger scientific community interested in the immunology of bottlenose 
dolphins, loggerhead sea turtles, spotted eagle rays, and bull sharks.  These reagents will 
be especially useful for those interested in using these animals as sentinel species within 
the larger context of Oceans and Human Health.  Secondary to developing these reagents, 
we demonstrate evidence that calculating antibody activities is a more sensitive and 
possibly more informative approach than calculating simple relative titers for quantifying 
antibody responses to pathogens of interest. 
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The common bottlenose dolphin (Tursiops truncatus) immune response, health, and the 
exploration of exposure to different pathogens have been conducted as part of the 
Atlantic bottlenose dolphin Health and Environmental Risk Assessment (HERA) project.  
However, no study to date has quantified serum titers against Streptococcus agalactiae 
and compared serum titers and antibody activities.  Serum from bottlenose dolphins has 
been collected over the past two decades from wild and managed-care populations.  
These samples include managed-care dolphins managed by the Georgia Aquarium (n = 
34) and the United States Navy Marine Mammal Program (n=63) and wild dolphins from 
the Charleston Harbor in South Carolina (n =80) and Indian River Lagoon in Florida 
(n=163).  Serum immunoglobulin G (IgG) recognition of Streptococcus agalactiae 
bacterial proteins were demonstrated through immunoprecipitation techniques.  
Bottlenose dolphin purified IgG recognized proteins from S. agalactiae.  Whole 
bacterium-specific IgG titers and antibody activities were quantified using enzyme-linked 
immunosorbent assays, and significant differences were observed between bottlenose 
dolphin serum titers and antibody activities.  Both serum titers and antibody activities 
demonstrated a strong correlation.  Relative titers were comparable across all years of 
serum collection compared to significant differences present between the wild Indian 
River Lagoon population during sampling years.  Managed-care dolphins had lower 





Infectious diseases emerging over the decades have become a serious and 
complex threat for humans, animals, and environmental health (Bossart, 2011).  Disease 
emergence has become a driver for environmental change due to its ability to cause the 
extinction of endangered species, alter habitats currently facing pressure from climate 
change and habitat fragmentation, and change ratios of predators, prey, and decomposers 
needed to maintain a healthy, productive ecosystem (Epstein et al., 2003).  Oceanic 
health has been linked to human health worldwide, and the need to understand the 
connections between the health of humans, animals, and the environments they inhabit is 
critical (Bossart, 2011).  Scientists have been utilizing marine sentinel species to provide 
a way to evaluate the aquatic ecosystem's health (Boersma, 2008; Bossart, 2011; Moore, 
2008).  Using this strategy, early indications about current or possible negative effects on 
animal health can allow for the characterization and management of impacts that could 
affect human and animal health (Bossart, 2011; Hazen et al., 2019).   
The common bottlenose dolphin (Tursiops truncatus), a member of Cetacea, is 
one of the best-known and most recognized marine mammal species (Vollmer and Rosel, 
2013).  It has been noted that due to their life-history traits and global distribution, that 
they could serve as a sentinel species (Wells et al., 2004).  These organisms carry out 
their lives immersed in water that brings with it an entirely different environment and 
exposure to a plethora of microbes and pathogens (Bossart et al., 2011).  Previous studies 
have noted exposures to and diseases from viruses, fungi, and bacteria.  These include the 
cetacean morbillivirus (Krafft et al., 1995; Taubenberger et al., 1996), the Lacazia loboi 
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fungus (Cowan, 1993), Erysipelothrix rhusiopathiae, Escherichia coli, Mycobacterium 
marinum, Vibrio carchariae, Vibrio cholerae, Vibrio parahemolyticus, and Vibrio 
vulnificus (Beck and Rice, 2003; Bossart et al., 2019).  A pathogen that has not yet been 
studied extensively in bottlenose dolphins is Streptococcus agalactiae.   
In the early 2000s, the first two characterizations of S. agalactiae in marine 
mammals were isolated from managed-care and wild bottlenose dolphins (Evans et al., 
2006; Zappulli et al., 2005).  S. agalactiae is a group B streptococcus strain that is a 
significant pathogen and has been of concern for terrestrial animals and farmed fishes.  It 
is known to be the cause of neonatal meningitis and mastitis in humans and cows, 
respectively (Amborski et al., 1983; Baker, 1997).  S. agalactiae has been observed to 
cause septicemia, necrotizing fasciitis, and large mortality events in a variety of aquatic 
organisms.  This bacterium has also been documented to have harmful effects in 
crocodiles, frogs, and an array of fish species (Amborski et al., 1983; Bishop et al., 2007).   
The immune system plays a crucial role in the pathogenesis and fate of infectious 
diseases in their hosts (Bossart et al., 2019).  As previously noted in the literature, 
measuring antibody responses to pathogens is a vital tool to understand bottlenose 
dolphin health.  Immunoglobulin M (IgM), IgG, and IgA have been confirmed to be 
critical constituents of the marine mammal immune system to identify and aid in the 
destruction of invading pathogens (Gelain and Bonsembiante, 2019).  Bottlenose 
dolphins produce IgG, which serves as the major antibody that aids in the protection and 
immunity against bacterial or viral infections (Zimmerman et al., 2010).  Previous studies 
have utilized monoclonal antibodies against bottlenose dolphin IgG to identify and gain 
 61 
an understanding of significant exposure events to different marine bacteria in different 
bottlenose populations (Beck and Rice, 2003; Fair et al., 2017) 
Bottlenose dolphin serum samples have been routinely collected from wild and 
managed-care dolphin facilities as a continuing effort of the Atlantic bottlenose dolphin 
Health and Environmental Risk Assessment (HERA) project.  Wild dolphins have been 
sampled from two estuarine areas: the Charleston Harbor in South Carolina and the 
Indian River Lagoon in Florida.  The Charleston Harbor site (CH) is an estuarine 
ecosystem that includes Ashley, Wando, and Cooper Rivers.  There is an effective tidal 
exchange, but the estuary is surrounded by seaports, growing urban development, and 
population, and contains a US Naval base (Reif et al., 2008).  There are two Superfund 
sites on the CH estuary that have been documented to be contaminated with polycyclic 
aromatic hydrocarbons, lead, copper arsenic, and dioxin (United States Environmental 
Protection Agency, 2021).  The Indian River Lagoon (IRL) site is a shallow-water 
ecosystem that comprises 40% of the Florida east coast.  The Indian River, Banana River, 
and Mosquito Lagoon all collectively form the IRL.  The tidal exchange rates are low 
between the lagoon and the Atlantic Ocean, which creates a longer residence time of 
pollutants in the lagoon (Barile, 2018).  Residential development and intense agricultural 
activity have resulted in increased freshwater inputs and water quality changes (Scott et 
al., 2002; Sigua et al., 2000).  Managed-care bottlenose dolphin samples have been 
collected from the Georgia Aquarium facilities and the United States Navy Marine 
Mammal Program (MMP) pod in San Diego, California.  The Georgia Aquarium 
dolphins in Atlanta, Georgia, are kept in a controlled artificial sea water environment.  
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The Georgia dolphin environment at Marineland, Florida, is outdoors with maintained 
natural water temperatures.  Both facilities use protein skimming, filtration, and water 
treatment (Fair et al., 2017).   
Previous work utilizing pathogen-specific responses in bottlenose dolphins has 
used serum antibody activities (Beck and Rice, 2003) and serum antibody titers (Bossart 
et al., 2019; Fair et al., 2017) to measure these responses to bacteria, fungi, and viruses.  
In this study herein, we aim to identify S. agalactiae proteins that play a role in the 
immune response in bottlenose dolphins through immunoprecipitation techniques, 
investigate differences in serum antibody titers and antibody activities to S. agalactiae in 
four different bottlenose dolphin populations, and add to the repertoire of data that has 
been reported for these bottlenose dolphin samples.  Immunoprecipitation (IP) is a 
method to identify molecules that interact with specific proteins that utilize a target 
protein-specific antibody along with protein A/G affinity beads (Kim et al., 2013).  To do 
this, a S. agalactiae culture will be grown and lysed.  Immunoprecipitation will be carried 
out with serum from bottlenose dolphins, followed by S. agalactiae lysate.  To observe 
any key immunogenic proteins, SDS-PAGE and Western blot analysis will be carried out.  
If there is a key immunogenic protein present that the bottlenose dolphin serum 
recognizes, the protein can be extracted and sequenced.  Once sequenced, the protein of 





3.2 Materials and Methods 
3.2.1 Bottlenose dolphin samples 
Bottlenose dolphin (Tursiops truncatus) serum samples were collected from 340 
individuals starting in July of 2003 to July of 2019.  These samples were collected from 
wild dolphins in the Indian River Lagoon in Florida (n=163) and the Charleston Harbor 
in South Carolina (n=80).  Samples were also collected from managed-care dolphins 
from the Georgia aquarium (n=34) and the Marine Mammal Program pod in San Diego, 
California (n=63).  These collections are part of an ongoing research effort for the 
Atlantic bottlenose dolphin Health and Environmental Risk Assessment (HERA) project.   
 
3.2.2 Purification of bottlenose dolphin Immunoglobulin G (IgG)  
Random bottlenose dolphin serum samples were used to create a pooled serum 
sample to be purified for IgG.  The pooled serum sample was made using 500 µL of 
bottlenose dolphin serum was taken from 20 different bottlenose dolphin serum samples.  
The pooled serum was centrifuged at 2,000 rpm to rid of any cell debris in the serum 
samples.  The supernatant was then used and filter sterilized using a 0.45 µm filter 
followed by a 0.2 µm filter. 
To purify IgG from bottlenose dolphin serum samples, a protein G column 
(ThermoFisher) were used.  The column was equilibrated by running 0.10 M Tris pH 8.0 
through the column, then 0.01 M Trish pH 8.0, followed by the pooled serum sample.  
The serum was passed through the column three times.  IgG samples were eluted by 
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running 0.05 M glycine pH 2.5 in 1 mL fractions through the column and collected.  Each 
of these 1 mL fractions has 1.0 M Tris pH 8.0 added to the aliquot. 
After collection, a standard BCA protein determination was performed for each 
aliquot to elucidate which fractions had IgG and the quantity present.  The Pierce® BCA 
Protein Assay reagents (Thermo Scientific) were used to determine the amount of protein 
on a 96 well plate according to the manufacturer's protocol.  A standard curve was 
generated from the known concentrations of the BCA standard wells and their optical 
density readings.  A line of best fit was generated and employed to determine the exact 
amount of protein that corresponds with each optical density reading.  The duplicates of 
the protein concentrations were averaged and considered the final protein concentration 
estimates for IgG.   
The purity of the bottlenose dolphin IgG sample was verified via SDS-PAGE.  
Samples from aliquots that showed positive protein amounts were combined with 5x 
Laemmli sample buffer with 2-Mercaptoethanol (2-ME).  These samples were boiled in 
water at 100oC for six minutes.  The samples were allowed to cool, and then the products 
were subjected to SDS-PAGE using 4-20% Mini-PROTEAN® TGX Stain-Free™ 
Protein Gels (BioRad).  For the gel, lane 1 contained the protein molecular weight marker 
(FroggaBio), followed by the pure IgG aliquot in lane 3.  The gel was run at 200V for 
approximately 40 minutes or until the dye front reached the bottom of the gel.  Once 
complete, the gel was stained with Coomassie blue for 16 hours and then detained using a 
30% methanol/10% acetic acid solution.  Once the gel was destained, the gel was imaged 
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using a ChemiDoc (Bio-Rad) imaging system and analyzed for purity using the molecular 
weight marker to reference size.   
 
3.2.3 Generation of a monoclonal antibody against the heavy chain domain of bottlenose 
dolphin IgG  
Procedures for immunizations, blood collection and spleen removal were carried 
out at the Godley Snell Animal facility under an approved animal use protocol.  Purified 
IgG from bottlenose dolphins was used to immunize 6-week old female Balb/c mice 
using previously described methods (Rice et al., 1998).  On day one, mice were 
administered a subcutaneous (s.c.) injection of 100 μg purified bottlenose dolphin IgG in 
0.9% saline containing TiterMax Gold adjuvant.  On day 14, the mice received a second 
s.c. injection of 50 μg of purified IgG with Freud's incomplete adjuvant (FIA).  Boosters 
of 50 μg of purified IgG were given at 21-day intervals.  On day 35, the booster was 
given in saline via s.c. immunization and on day 56 intraperitoneally.  Five days after the 
last immunization, slow lethal CO2 asphyxiation and bilateral pneumothorax were used to 
sacrifice the mice.  The spleens were removed and dissociated into single cells by gently 
holding the pulp with tweezers and using a scalpel blade.  Cells were washed twice via 
centrifugation and then fused with Sp02-Ag14 myeloma cells (ATCC) in the presence of 
50% polyethylene glycol 4000 (PEG 4000) (Fisher Scientific) using previously published 
techniques.  The resulting hybridomas were cultured, screened, and cloned as previously 
described (Rice et al., 1998).  Supernatants from cloned hybridomas were used as the 
source of monoclonal antibodies (mAb).   
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3.2.4 Validation monoclonal antibody utilizing Western blot analysis 
 Bottlenose dolphin whole serum samples and purified IgG were diluted and 
loaded into a 4-20% MiniPROTEAN® TGX Stain-FreeTM Protein Gel (BioRad) and 
subjected to SDS-PAGE as previously described above.  A BLUelf Prestained Protein 
molecular weight marker (FroggaBio) was used to serve as a reference.  The proteins on 
the gel were then be transferred to an Immun-Blot® PVDF membrane at 100V for one 
hour at 4oC.  After the transfer, blots were blocked for 16 hours with 10% fetal calf serum 
in 0.01M PBS at 4°C.  The blots were then probed with the mAbs against bottlenose 
dolphin IgG (mAb KA-6), followed by three 5-minute washes with 0.05% PBS Tween 20 
(PBST).  Lastly, blots were incubated with goat anti-mouse IgG-Alkaline phosphatase 
buffer (AP) (1:1,000 in PBS; Thermo-Fisher), following the same incubation and wash 
procedure as the previous two steps.  The blot was developed with 5-bromo-4-chloro-3'-
indolyphosphate p-toluidine salt (BCIP) and nitro-blue tetrazolium chloride (NBT) in AP 
buffer, allowing the AP activity to be visualized and recorded.   
 
3.2.4 Preparation of serum prior to immunoprecipitation steps. 
  To purify IgG from bottlenose dolphin serum, 500 µL of bottlenose dolphin 
serum was taken from 20 different bottlenose dolphin serum samples.  The pooled serum 
was centrifuged at 2,000 rpm to rid of any cell debris in the serum samples.  The 
supernatant was then used, and filter sterilized using a 0.45 µm filter followed by a 0.2 
µm filter.  The filtered serum was then combined with one milliliter of 1 M Tris pH 8.   
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3.2.5 Streptococcus agalactiae lysate for immunoprecipitation 
To create a sample of Streptococcus agalactiae lysate, S. agalactiae was grown at 
approximately 33ºC for 24 hours in tryptic soy broth media.  The bacteria suspension was 
then centrifuged at 2500 rpm for 15 minutes.  The supernatant was removed, and the 
pellet was resuspended in 20 mL of 0.01M phosphate-buffered saline (PBS).  This 
procedure was repeated two more times.  The pellet was resuspended in denaturing buffer 
provided in the QIAexpress Ni-NTA Fast Start kit (Qiagen).  The sample was vortexed 
and subjected to three freeze-thaw cycles.  Sonication was also used to further assist in 
the breaking of the bacterial walls and DNA of S. agalactiae.   
An S. agalactiae sample was combined with 5x Laemmli sample buffer with 2-
Mercaptoethanol (2-ME) and boiled in water at 100oC for six minutes.  The sample was 
allowed to cool, and then the product was subjected to SDS-PAGE using 4-20% Mini-
PROTEAN® TGX Stain-Free™ Protein Gels (BioRad).  For the gel, lane 1 contained the 
BLUelf Prestained Protein molecular weight marker (FroggaBio), followed by different 
amounts of the S. agalactiae sample across the gel; 2 µL,4 µL,8 µL,16 µL, and 30 µL.  
The gel was run at 200V for approximately 40 minutes or until the dye front reached the 
bottom of the gel.  Once complete, the gel was stained with Coomassie blue for 16 hours 
and then detained using a 30% methanol/10% acetic acid solution.  Once the gel was 
destained, the gel was imaged using a ChemiDoc (Bio-Rad) imaging system and 
analyzed for the presence of different S. agalactiae proteins using the molecular weight 




To immune-precipitate Streptococcus agalactiae lysate proteins, a protein G 
column (Thermo-Fisher) was used to capture bottlenose dolphin IgG.  To equilibrate the 
column, three column washes of 0.1 M Tris pH 8.0 were applied to the column, followed 
by three column washes of 0.01 M Tris pH 8.0.  Then, 10 mL of pooled bottlenose 
dolphin serum combined with 10 mL of 1 M Tris pH 8.0 was run through the column five 
times.  The column was washed five times with 0.1 M Tris pH 8.0, and the S. agalactiae 
lysate solution was added to the column.  The bacterial lysate solution was run through 
the column twice, followed by three washes with 1 ml 0.1 M Tris pH 8.0.  Each wash of 
the sample was collected in a 15 mL centrifuge tube.  Finally, IgG bound to S. agalactiae 
was eluted using six milliliters of 0.05 M glycine pH 2.5 in 500 µL fractions.  To each of 
these 500 µL fractions, 50 µl of 1.0 M Tris pH 8.0.  In addition to the 12 elution samples, 
200 µL was taken from the S. agalactiae lysate sample before immunoprecipitation and 
after the immunoprecipitation.   
A standard BCA protein determination was performed for each of the 12 fractions 
of purified IgG bound to S. agalactiae, the pre-and post-immunoprecipitation samples, 
and the three washes after the immunoprecipitation that were collected.  Protein 
determination was performed using Pierce® BCA Protein Assay reagents (Thermo 
Scientific).  Each sample was measured in duplicate, and the average was taken and 




3.2.7 Validation of Immunoprecipitation utilizing SDS-PAGE and Western blot analysis 
To validate the success of the immunoprecipitation assay, the 12 fractions of S. 
agalactiae lysates bound to dolphin IgG and the pre-and post-immunoprecipitation 
samples were diluted and loaded into two 4-20% MiniPROTEAN® TGX Stain-FreeTM 
Protein Gel (BioRad) and subjected to SDS-PAGE as previously described above.  A 
protein molecular weight marker was used to serve as a reference.  One of the gels was 
stained according to the previously mentioned Coomassie blue staining procedure.  The 
proteins on the second gel were transferred to an Immun-Blot® PVDF membrane at 
100V for one hour at 4oC.  After the transfer, the blot was blocked for 16 hours with 10% 
fetal calf serum in 0.01M PBS at 4°C.  The blot was then probed with the mAb against 
bottlenose dolphin IgG (mAb KA-6), followed by three 5-minute washes with PBST.  
Lastly, the blot was incubated in anti-mouse IgG-alkaline phosphatase buffer (AP) 
(1:1,000 in PBS; Thermo-Fisher), following the same incubation and wash procedure as 
the previous two steps.  The blot was developed with 5-bromo-4-chloro-3'-
indolyphosphate p-toluidine salt (BCIP) and nitro-blue tetrazolium chloride (NBT) in AP 
buffer, allowing the AP activity to be visualized and recorded.   
 
3.2.8 Development of enzyme-linked immunosorbent assays (ELISAs) for quantifying 
Streptococcus agalactiae specific IgG  
To perform the enzyme-linked immunosorbent assays (ELISAs), S. agalactiae 
was again grown at approximately 33ºC for 24 hours in tryptic soy broth media.  The 
bacteria suspension was then spun down at 2500 rpm for 15 minutes.  The supernatant 
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was removed, and the pellet was resuspended in 20 mL of 0.01M phosphate-buffered 
saline (PBS).  This procedure was repeated two more times, but the pellet was 
resuspended in 10 mL of PBS following the last centrifugation.  To determine the optical 
density, 100 μL of the S. agalactiae was placed in duplicate in the wells of a 96 well plate 
and recorded at 600 nm.  The bacterial suspension was then diluted to the established 
optical density of 0.200 for S. agalactiae.   
 High binding 96 well plates (Medi-sorb, ThermoFisher) were coated for 16 hours 
at 4° C with 50 μL of 0.1 mg/mL poly-D-lysine in distilled water in each well.  The plates 
were then washed in 0.05% PBST two times.  The optimized bacterial suspension was 
taken, and 75 μL of the bacteria was added to all the wells in the 96 well plates.  The 
plates were centrifuged at 2500 rpm for 5 minutes and then incubated at room 
temperature for 15 minutes.  Following the 15-minute incubation, the plates were washed 
twice in PBS, and 100 μL of glycine-BSA (100 mM glycine with 1% BSA) was added to 
the plates to then incubate at room temperature for 30 minutes.  The plates were washed 
in PBS two times and let dry at room temperature.   
 The dried plates each received 100 μL of 5% BSA blocking buffer, which 
incubated for one hour at room temperature.  Bottlenose dolphin serum dilutions were 
made by adding five μL of serum from each individual dolphin into 990 μL PBS in 1.5 
mL snap cap tubes to result in a final concentration of 1:200.  In addition to the individual 
samples, a pooled serum sample was made by combining 300 μL of the bottlenose 
dolphin pooled serum resource and added it into 29.7 mL of PBS, resulting in a 1:100 
final concentration.  To each plate, 150 μL of each serum suspension and pooled standard 
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sample were added in duplicate so that each plate could have eight samples and a 
standard curve.  The remaining wells on each plate had 75 μL of PBS added to them.  
The samples were then serially diluted down the plate, with the last dilution being 
1:3200.  Four wells on each plate contained 75 μL of PBS to be used for controls (Figure 
3.1).   
 The plates were then incubated with the dilutions of bottlenose dolphin serum 
overnight at 4oC.  The following day, the plates were washed three times in 0.05% PBST 
via submersion, and 75 μL of monoclonal bottlenose dolphin anti- IgG (mAb KA-6) 
diluted 1:3 in media was added to the plates.  After two hours of incubation at room 
temperature, plates were washed three times in 0.05% PBST.  Goat anti-mouse IgG AP 
(1:1000) was added to the plates in 75 μL quantities and incubated at room temperature 
for one hour.  The plates were washed five times in 0.05% PBST, and 75 μL of 1 mg/mL 
of p-nitrophenol in AP buffer was added to each well.  After an incubation period of 16 
minutes, 75 μL of 1 M sodium hydroxide solution was added to the plates to stop the 







Figure 3.1. Experimental setup for ELISA.  The experimental setup shown allowed for 
eight bottlenose dolphin (BD) samples starting at a dilution of 1:200, a standard (STD) 
curve created from pooled bottlenose dolphin serum, and four wells for controls; primary 
antibody (1o) and secondary antibody (2o). 
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 Antibody activity for each sample was determined using previously published 
methods (Arkoosh and Kaattari, 1991).  In brief, dilutions were expressed as the 
equivalent volume of the undiluted serum.  This was calculated by taking the product of 
the dilution volume (75 µl) and each dilution.  The standard curve generated with pooled 
serum was used to determine the volume of serum at the 50% point of the maximum O.D.  
obtained for the standard pooled serum.  This volume was then assumed to be the 
equivalent of one unit of antibody activity (
1 𝑢𝑛𝑖𝑡
𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑠𝑒𝑟𝑢𝑚
).  Each sample was graphed 
against the 50% point of the maximum O.D.  from the standard curve to determine the 
volume of the test sample at that 50% point of the standard.  Antibody activity for each of 
the test samples was calculated using the following equation: 
 𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑜𝑓 𝑇𝑒𝑠𝑡 𝑆𝑎𝑚𝑝𝑙𝑒 =  (𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑜𝑓 𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑)  × (
50% 𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑
50% 𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑇𝑒𝑠𝑡 𝑆𝑎𝑚𝑝𝑙𝑒
) 
The values for serum titers against the bacteria were calculated as relative optical density 
(O.D) multiplied by the serum dilution factor of 1:200 for each individual (Karsten and 
Rice, 2006; Rodgers et al., 2018).   
GraphPad Prism's statistical software was used to compare averages using a 
previously set α-value of 0.05 and analysis of variance (ANOVA) with Bonferroni's 
multiple contrast post-hoc tests whenever differences were noted by the ANOVA.  In 
addition, serum titer levels were compared against logarithmically transformed activities 
using regression analysis and Pearson’s correlation to examine if bottlenose dolphin 





3.3.1 Analysis of Immunoprecipitation 
Analysis of the SDS-PAGE of different loading volumes of S. agalactiae whole 
lysate under reducing conditions demonstrates that four to eight microliters of lysate are 
optimal to observe clean banding patterns (Figure 3.2). 
  
Figure 3.2. SDS-PAGE of Streptococcus agalactiae lysate.  Lane 1 contains the protein 
molecular weight marker.  Lane 2 contains 2 µL of lysate, lane 3 contains 4 µL of lysate, 
lane 4 contains 8 µL of lysate, lane 5 contains 16 µL of lysate, and lane 6 contains 30 µL 
of lysate.   
75 kDa- 
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The immunoprecipitation technique successfully immunoprecipitated S. 
agalactiae proteins interacting with bottlenose dolphin IgG (Figure 3.3, Figure 3.4).  
Lanes four through six demonstrate successful washing of the column before the elution 
aliquots present in lanes seven through 12.  Four different dominant bands can be 
observed in lanes 10 and 11, which occur at approximately 75 kDa, 55 kDa, 25 kDa, and 
13 kDa.  The bands at 55 kDa and 25 kDa correspond to the heavy and light chain of 
bottlenose dolphin IgG, respectively.  There also appears to be an IgG degradation 
product that appears just under the heavy chain of IgG.  The other two bands that appear 










Figure 3.3. SDS-PAGE of samples from immunoprecipitation of S. agalactiae 
lysates.  Lane 1 contains the protein molecular weight marker.  Lane 2 contains the S. 
agalactiae lysate sample prior to immunoprecipitation.  Lane 3 contains the S. agalactiae 
sample after immunoprecipitation.  Lane 4 through 6 contain washes one through three.  
Lane 7 through lane 18 contain the 12 elutions from the immunoprecipitation assay.  Four 
different dominant bands can be seen in lanes 10 and 11, occurring at approximately 76 





75 kDa - 
25 kDa - 
11 kDa - 
63 kDa - 






Figure 3.4. Western blot analysis of samples from immunoprecipitation of S. 
agalactiae lysates with mAb KA-6 identifies bottlenose dolphin IgG heavy chains.   
Lane 1 contains the protein molecular weight marker.  Lane 2 contains the S. agalactiae 
lysate sample prior to immunoprecipitation.  Lane 3 is the S. agalactiae sample after 
immunoprecipitation.  Lane 4 through 6 contain washes one through three.  Lane 7 
through lane 18 contain the 12 elutions from the immunoprecipitation assay.  Dominant 
bands can be seen in lanes 10 and 11, occurring at approximately 55 kDa and 45 kDa, 
bottlenose dolphin IgG heavy and degradation product, respectively. 
  
75 kDa - 
48 kDa - 
63 kDa - 
MW   2      3      4      5     6      7      8      9     10    11    12    13     14    15    16    17    18 
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3.3.2 ELISA results for all dolphins sampled 
Statistical analysis of the serum titer levels against S. agalactiae demonstrates no 
significant differences between titer levels in sera collected during different years for all 
four different dolphin populations (Figure 3.5A).  There were statistically significant 
differences (p < 0.05, p < 0.001, p < 0.0001) of serum antibody activity against S. 
agalactiae from sera collected in 2003, 2004, 2010, 2011, 2012, 2013, and 2015 (Figure 
3.5B).  Antibody activity notably increased in 2015 compared to all other years.   
The relationship between sera relative titer levels and antibody activity was 
investigated and demonstrated a relationship between these two indices (Figure 3.6).  A 
positive correlation (r = 0.6909) was observed, and this relationship was significant for 
all dolphins sampled for this study (p < 0.0001, n = 340).  This data indicates that titers 
would indicate antibody activity, and antibody activity would indicate titers against S. 
agalactiae in bottlenose dolphin populations.   
After analyzing bottlenose dolphin data as a whole, bottlenose dolphin 
populations were split based on their different sampling locations.  Relative titers and 
antibody activities were analyzed for IRL (Figure 3.7A), CH (Figure 3.7B), Aq.  
(Figure 3.7C), and MMP (Figure 3.7D) populations.  All four populations had 
statistically significant differences between serum relative titers and antibody activity (p 




























































Figure 3.5. Enzyme-linked immunosorbent assay (ELISA) for antibody titers and 
antibody activities against S. agalactiae from all bottlenose dolphin samples.  (A) 
relative antibody titers at a dilution of 1:200 and (B) antibody activities.  No significant 
differences were seen between years of collection for relative titers.  Statistical analysis 
indicated significant differences between antibody activities against S. agalactiae from 
sera collected in 2003, 2004, 2010, 2011, 2012, 2013, and 2015.  *Indicates statistical 
significance of <0.05; *** indicates statistical significance of <0.001; **** indicates 
















Figure 3.6. Simple correlation analysis of relative titers to antibody activities for all 
bottlenose dolphin populations.  There was a significant correlation between antibody 
activity and relative titers for all dolphins sampled (Charleston Harbor, Indian River 
Lagoon, Georgia Aquarium, and Marine Mammal Program).   
 












































































































































Figure 3.7. Relative titer and antibody activities in bottlenose dolphins in wild 
populations (Charleston Harbor (CH), Indian River Lagoon (IRL)) and managed-
care (Georgia Aquarium (Aq.) and Marine Mammal Program (MMP).  Significant 
differences between the mean relative titer and mean activities were found for the IRL 
(A), CH (B), Aq. (C) and MMP (D).  **** indicates statistical significance of <0.0001.  
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Correlation analyses were also completed to determine if the same observed 
trends for all dolphins held true in these different populations.  Dolphins from the Indian 
River Lagoon have a strong correlation (r = 0.7239) with a significant relationship 
between relative titer and antibody activity (p < 0.0001, n = 162; Figure 3.8A).  
Charleston Harbor dolphins have a strong correlation (r = 0.7503) with a significant 
relationship between relative titer and antibody activity (p < 0.0001, n = 80; Figure 
3.8B).  Dolphins that are kept in managed-care at the Georgia Aquarium have the 
strongest correlation (r = 0.8624) with a significant relationship between relative titer and 
antibody activity (p < 0.0001, n = 34; Figure 3.8C).  Lastly, the other population of 
managed-care dolphins, MMP, also demonstrated a strong correlation (r = 0.7087) with a 
significant relationship between relative titer and antibody activity (p < 0.0001, n = 63; 
Figure 3.8D).  These data indicate that on the population level, titers are indicative of 







































l) r = 0.7239, p < 0.0001 ****
n = 162 pairs
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l) r = 0.7087, p < 0.0001 ****
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Figure 3.8. Simple correlation analysis of relative titers to antibody activities for 
bottlenose dolphins in wild populations (Charleston Harbor (CH), Indian River 
Lagoon (IRL), and managed-care (Georgia Aquarium (Aquarium) and Marine 
Mammal Program (MMP).  Significant correlations were found between relative titers 
and antibody activities in bottlenose dolphins from the IRL (A), CH (B), Aq. (C) and 
MMP (D).  The relationship between relative titers and activities was significant in all 
four populations (p < 0.0001). 
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3.3.3 ELISA results for the different populations across sampling dates 
Statistical analysis of serum titer levels against S. agalactiae indicated that there 
are no significant differences between titer levels collected at different time points for 
dolphins in the wild (IRL (Figure 3.9A) and CH (Figure 3.9B) and managed-care 
dolphins (Georgia Aquarium (Figure 3.9C) and MMP (Figure 3.9D).  Observable 
differences were seen in titer levels for dolphins in managed care.  Dolphins from the 
Georgia Aquarium appear to have variable titers, whereas the MMP dolphins are more 
clustered together.  
There were significant differences (p < 0.05, p < 0.01, p <0.001) for serum 
antibody activity against S. agalactiae from sera collected in July of 2015 compared to 
July 2003, June 2004, June 2010, June 2011, and June 2012 for dolphins in the IRL 
(Figure 3.10A).  There were no statistically significant differences for CH dolphins 
(Figure 3.10B) and managed-care dolphins (Georgia Aquarium (Figure 3.10C) and 
MMP (Figure 3.10D).  Similar to serum titer levels, observable differences were seen in 
antibody activities for dolphins in managed care.  Dolphins from the Georgia Aquarium 
appear to have variable antibody activities, whereas the MMP dolphins are clustered 









































































































































































































Figure 3.9. Enzyme-linked immunosorbent assay (ELISA) of relative titers against 
S. agalactiae in bottlenose dolphins from wild populations (Charleston Harbor 
(CH), Indian River Lagoon (IRL)) and managed-care (Georgia Aquarium 
(Aquarium) and Marine Mammal Program (MMP).  There were no significant 
differences observed between sampling dates for dolphins from the IRL (A), CH (B), Aq. 







































































































































































































































Figure 3.10.  Enzyme-linked immunosorbent assay (ELISA) antibody activities 
against S. agalactiae in bottlenose dolphins from wild populations (Charleston 
Harbor (CH), Indian River Lagoon (IRL)) and managed-care (Georgia Aquarium 
(Aquarium) and Marine Mammal Program (MMP).  There were significant 
differences observed between 2003, 2004, 2010, 2011, 2012, and 2015.  There were no 
significant differences observed between sampling dates for dolphins from the CH (B), 
Aq. (C), and MMP (D).  *Indicates statistical significance of <0.05; ** indicates 
statistical significance of <0.01; *** indicates statistical significance of <0.001. 
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3.3.4 ELISA results for Charleston Harbor and Indian River Lagoon in 2003 and 2004 
As previously mentioned, prior work with these serum samples specifically 
investigated immune responses to other common marine bacteria and compared CH and 
IRL dolphins during 2003 and 2004.  These years and locations were also investigated for 
this study.  Statistical analyses of serum titer and antibody activity results against S. 
agalactiae in the CH and IRL did not indicate significant differences between sampling 
locations and years for titers (Figure 3.11A) and antibody activities (Figure 3.11B).   
Differences in relative titers and antibody activities between IRL, Georgia 
Aquarium, and MMP dolphins for 2011 and 2012 were also investigated.  Statistical 
analyses demonstrated significant differences for managed-care dolphins in 2012 (p < 
0.05; Figure 3.12A).  No significant differences were observed for serum antibody 










Figure 3.11.  Enzyme-linked immunosorbent assay (ELISA) for relative antibody 
titers and antibody activities against S. agalactiae in the Charleston Harbor and 
Indian River Lagoon in 2003 and 2004 results No significant differences were 
observed between sampling locations and years for titers (A) and antibody activities (B). 
 
  








































































































































Figure 3.12.  Enzyme-linked immunosorbent assay (ELISA) of relative antibody 
titers and antibody activities against S. agalactiae in the Indian River Lagoon (IRL), 
Georgia Aquarium (Aq), and Marine Mammal Program (MMP) in 2011 and 2012.  
Significant differences were observed between aquarium and MMP serum titers (A) in 
2012.  No other significant differences were observed between sampling locations and 
years for titers and antibody activities (B).  * indicates statistical significance of <0.05. 
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3.3.5 ELISA results for wild and managed care populations across sampling dates 
Differences between sampling dates for each population were investigated.  
Charleston harbor dolphins had no statistically significant differences between serum titer 
levels and serum antibody activity for different sampling years (Figure 3.13).  Dolphins 
sampled from the IRL had no statistically significant differences observed for serum titer 
levels across sampling years (Figure 314A).  However, there were statistically significant 
differences (p < 0.05, p <0.01, p <0.001) for serum antibody activity for 2015 compared 
to 2003, 2004, 2010, 2011, and 2012 in dolphins from the IRL.  This trend was also 
observed for the serum antibody activities of all dolphins sampled (Figure3.15B).  
Managed-care dolphin from the Georgia aquarium serum titer level trends were observed.  
Both serum titer level (Figure 3.15A) and serum antibody activity (Figure 3.15C) 
demonstrate two different groups.  Roxy, Pebbles, Sunny, Alvin, and Phebe have higher 
serum titer levels and antibody activities than the other individuals at the aquarium.  
MMP dolphins have more tightly clustered serum titer levels (Figure 3.15B) and 























































Figure 3.13.  Enzyme-linked immunosorbent assay (ELISA) for relative titers and 
antibody activities against S. agalactiae in dolphins from the Charleston Harbor in 
2003, 2004, and 2013.  No significant differences were observed between titer-titer or 

























































































Figure 3.14.  Enzyme-linked immunosorbent assay (ELISA) for antibody titers and 
antibody activities against S. agalactiae from the Indian River Lagoon by year.  No 
significant differences were observed for relative titers(A) between years.  Significant 
differences were observed between Indian River Lagoon (IRL) bottlenose dolphin 
activities (B) from the years 2003, 2004, 2010, 2011, 2012, and 2015.  *Indicates 
statistical significance of <0.05; ** indicates statistical significance of <0.01; *** 




















































































































































































































































Figure 3.15.  Enzyme-linked immunosorbent assay (ELISA) for antibody titers and 
antibody activities against S. agalactiae in managed-care dolphins by month/year 
results.  The Georgia Aquarium (Aq.) dolphins were observed to have two distinct 
groups for both relative titers (A) and antibody activity (B).  Likewise, the Marine 
Mammal Protection (MMP) dolphins also demonstrate two different groups for relative 
titers (B) and antibody activities (D). 
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3.3.6 ELISA results in CH (2011), IRL (2013), and GA Aquarium and MMP (2011-2012) 
Lastly, the serum titer and antibody activity sampling data results against S. 
agalactiae were compared for bottlenose dolphins in wild populations in 2011 and 2013 
and managed-care populations in 2011 and 2012.  There were no statistically significant 
differences in serum titer levels between populations (Figure 3.16A).  There were 
statistically significant differences (p < 0.05, p <0.01, p <0.001) in serum antibody 
activity between CH dolphins and the IRL, Georgia aquarium, ad MMP dolphins (Figure 
























































Figure 3.16.  Enzyme-linked immunosorbent assay (ELISA) for antibody titers and 
antibody activities against S. agalactiae in bottlenose dolphins from wild populations 
(Charleston Harbor (CH), Indian River Lagoon (IRL)) and managed-care in 2011 
and 2012 (Georgia Aquarium (Aquarium) and Marine Mammal Program (MMP) in 
2011 and 2013.  No significant differences were observed between sampling data and 
populations for relative titers (A).  Significant differences were observed for antibody 
activities (B) between MMP, Aq., IRL, and CH populations.  *Indicates statistical 
significance of <0.05; ** indicates statistical significance of <0.01; *** indicates 






Upon examination of the SDS-PAGE and Western blot from the 
immunoprecipitation assay, it is clear that there are proteins from S. agalactiae that 
interact with bottlenose dolphin IgG.  This suggests that purified IgG from bottlenose 
dolphin serum is binding to proteins from S. agalactiae lysate.  The Western blot was 
probed with anti-bottlenose dolphin IgG (KA-6), which is specific for the heavy chain of 
bottlenose dolphin IgG.  The banding patterns present on the blot are consistent with the 
expected molecular weights of the heavy chain of IgG.  However, it is important to note 
that a degradation product appears just under the band of IgG.  The degradation product 
has been consistent across all screening blots throughout this study and others (Nollens et 
al., 2007).  Two other dominant proteins were also observed and had molecular weights 
around 76 kDa and 13 kDa.  Based on their molecular weights, we can confirm that they 
are not bottlenose dolphin IgG or IgM proteins.  It is likely that these proteins are from S. 
agalactiae and are proteins that are involved in the immune response to this pathogen in 
dolphins.  Proteomics work should be conducted to identify these unknown and 
potentially key proteins further.  Future work should be focused on carrying out 
proteomics on these proteins.  If key immunogenic proteins are identified, they can serve 
to generate a vaccine against S. agalactiae.   
There were no significant differences seen between years of sampling for all 
bottlenose dolphin samples.  However, there were statistically significant differences for 
serum antibody activity against S. agalactiae between sera collected in 2003, 2004, 2010, 
2011, 2012, 2013, and 2015 for all dolphins sampled.  Significant differences were 
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observed in serum titers and antibody activity for all bottlenose dolphins and bottlenose 
dolphin samples divided into sampling populations.  There was also a strong correlation 
and significant relationship between serum titers and antibody activity for all dolphin 
samples and bottlenose dolphins divided into their sampling populations.  This 
demonstrates that serum titers and antibody activities may be indicative of one another.  
This could be useful in future experiments as antibody activity is a laborious index to 
determine, whereas serum titers are more feasible and quicker.  However, antibody 
activity could provide more information when serum titers do not differ significantly.   
Serum titers against S. agalactiae did not differ statistically for wild bottlenose 
dolphin populations (IRL and CH) and managed-care dolphins (Aquarium and MMP).  
There were significant differences for serum antibody activity against S. agalactiae from 
sera collected in July of 2015 compared to July 2003, June 2004, June 2010, June 2011, 
and June 2012 for dolphins in the IRL.  This increase could be attributed to the poor 
water quality that is known for this area.  The Indian River Lagoon had reports of an algal 
bloom during the middle of 2015, which affected many portions of the lagoon.  These 
algal blooms are due to sewage and anthropogenic inputs.  However, the sample size is 
small (n =4).  There were no statistically significant differences between CH dolphins and 
managed-care dolphins (Georgia Aquarium and MMP).  The dolphins from the Georgia 
Aquarium were more variable for both serum titers and antibody activity over the 
different collection time points in contrast to the MMP dolphins, which were more 
consistent.  These differences observed between managed-care dolphin populations are 
likely due to differences in habitat.  Georgia aquarium dolphins are kept in different 
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interconnected pools.  The MMP dolphins are kept in a netted open water enclosure in the 
San Diego Bay are exposed to local conditions of the bay (Fair et al., 2017).  Also, these 
dolphins were sampled at different time points throughout the year rather than being 
sampled once like the CH and IRL populations.   
The wild bottlenose dolphin populations in the Charleston Harbor, SC, and Indian 
River Lagoon, FL, have been of focus to researchers for many years in part of a 
collaborative effort to assess the overall health of these two regions (Fair and Bossart, 
2005).  Many studies have been conducted investigating the immune responses to 
pathogens and the overall health of these organisms that were sampled in 2003 and 2004 
(Fair et al., 2007; Goldstein et al., 2006; Reif et al., 2009).  To date, no studies have been 
conducted investigating the immune responses in the serum samples to S. agalactiae.  
Statistical analyses did not demonstrate any significant differences in 2003 and 2004 
between bottlenose dolphin serum titers or antibody activity from individuals from the 
CH or IRL.  However, dolphins were seropositive against S. agalactiae, indicating 
exposures high enough to induce an immune response to this pathogen.   
Comparisons between IRL and managed-care bottlenose dolphins for the years 
2011 and 2012 were also made.  In this case, the managed-care dolphins were to serve as 
a control.  Statistical analyses demonstrated significant differences between the two 
managed care populations in 2012.  These differences could be due to the difference in 
water present in their managed habitats.  In addition, there are multiple samples taken 
from the same dolphins in the managed-care populations throughout the year.  In 
contrast, wild dolphin samples were collected once from each organism during the 
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sampling period.  There were no statistical differences observed between populations and 
years for bottlenose dolphin serum antibody activity.   
Due to the extensive work that has been completed on these bottlenose dolphin 
samples over the dates of collection at CH and IRL, we wanted to look at all serum 
samples at these locations.  Serum titer and antibody activity increased from 2004 to 
2013, and there were no statistical differences between titer-titer and activity-activity 
relationships between 2003, 2004, 2013.  The Charleston Harbor has been increasing in 
shipping activity and expanding ports.  In 2010, plans for new cruise terminals were 
announced and finalized.  In 2011, the Charleston Harbor Deepening Project began, and 
the port has seen increases in activity each coming year (South Carolina Ports, 2021).  
With increases in shipping activity, the harbor is likely to have an influx of ballast water 
from shipping vessels which has been documented to carry pathogens, including 
pathogenic Streptococcus species (Altug et al., 2012).  The Indian River Lagoon 
bottlenose dolphin serum titers did not have statistically significant differences.  
However, serum antibody activity demonstrated statistically significant differences 
between 2015 and 2003,2004, 2010, 2011, and 2012.  The antibody activity in 2015 was 
higher than in previous years.  The sampling of the IRL bottlenose dolphin population 
was completed in July of 2015.  In May of 2015, Hurricane Ana formed off the east coast 
of Florida bringing with it increased levels of rainfall.  During periods of increased 
rainfall in which the sewer collection system could be exceeded, combined sewer 
overflow can result.  It is possible that the combination of these two events introduced an 
increased amount of S. agalactiae and other bacteria into the marine environment. 
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The managed-care populations are kept in two different types of habitats while in 
captivity.  As previously mentioned, the Georgia Aquarium dolphins are kept in three 
interconnected pools, and the MMP dolphins are kept in a netted area inside the San 
Diego Bay in California.  The Georgia Aquarium dolphins are kept in consistent water 
parameters throughout the year, while the MMP dolphins are exposed to ambient water 
and air temperatures throughout the year.  The serum titer levels against S. agalactiae in 
the aquarium dolphins appear to split the population into two separate groups.  This is 
also consistent when observing serum antibody activity in aquarium individuals.  Five 
individuals appear to have higher serum titer levels and antibody activities compared to 
the other five.  These differences could be attributed to the life history of these dolphins, 
sex, age, and time spent at the aquarium.  Three of the 10 Georgia Aquarium dolphins 
sampled came from the wild, and the remainder were born under human care (Fair et al., 
2017).  The MMP dolphins are more tightly clustered for both serum titer and antibody 
activity.  Two dolphins in the MMP population were wild-caught while the others were 
all born in the MMP (Fair et al., 2017).  This could be the reasoning for the tighter 
clustering and consistency of titer and antibody activity in the MMP population.   
Previous research was conducted on bottlenose dolphin serum samples collected 
from the IRL population in July of 2011, CH population in August of 2013, the Georgia 
Aquarium, and MMP populations in 2011 through 2012(Fair et al., 2017).  This study 
investigated immune and endocrine responses in these wild and managed care 
populations.  Their findings suggested that the immune systems of wild dolphins were 
more upregulated than dolphins in managed care.  However, their study did not include 
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immune responses to S. agalactiae (Fair et al., 2017).  Using samples from those 
sampling years and populations to complement their previous work, no significant 
differences between serum titer levels for wild and managed populations were observed 
in this study.  There were significant differences between serum antibody activity for the 
different bottlenose dolphin populations.  The wild CH bottlenose dolphin serum 
antibody activity differed significantly and was greater when compared to the IRL, 
Georgia Aquarium, and MMP populations.  These differences could be accredited to the 
amount of shipping and human traffic present in the Charleston Harbor, SC area.  
Pathogenic streptococci can be introduced to the marine environment by shipping traffic 
and ballast water (Altug et al., 2012).  Also, animals such as seabirds (Nelson et al., 
2008) and wastewater introduced through rivers and stormwater (Fries et al., 2008) have 
been suggested to be sources of streptococcus and other bacteria in the marine 
environment.  The CH estuary is a very active seaport, surrounded by human 
development, and has three different rivers that flow in this estuary (Reif et al., 2008), 
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Conclusion and Future Directions 
 
 
The purpose of this research was to develop a monoclonal antibody against 
bottlenose dolphin (Tursiops truncatus) immunoglobulin G (IgG) to aid in the 
quantification of serum titers and antibody activities against Streptococcus agalactiae.  
The development of the monoclonal antibody against bottlenose dolphin IgG progresses 
the understanding of the secondary immune response in these organisms.  In addition, the 
monoclonal antibody was employed in immunoprecipitation to determine specific 
protein-protein interactions between bottlenose dolphin IgG and S. agalacatiae.  Lastly, 
the monoclonal antibody generated allowed for quantifying serum titers and antibody 
activities through the development of enzyme-linked immunosorbent assays.   
In this study, three different monoclonal antibodies were successfully generated.  
The generated monoclonal antibody against bottlenose dolphin IgG (KA-6) recognizes 
the heavy chain of bottlenose dolphin IgG.  The monoclonal antibodies created against 
bull shark IgM or spotted eagle ray IgM recognize the light chains of IgM in these 
species.  These three antibodies could serve to be useful in furthering research to answer 
questions about marine organism health.   
This study provides the first comparison of serum titers and antibody activity 
utilizing different marine vertebrates.  The development of the different marine vertebrate 
monoclonal antibodies served useful in comparing serum antibody titers and antibody 
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activities in these organisms.  Although the values for serum titers and antibody activity 
differ in terms of the range of numbers, not all titer and antibody activities differed 
significantly.  A strong correlation was observed between bull shark serum titers and 
antibody activities.  Due to this strong relationship, serum titers could give potential 
estimates for antibody activities due to the laborious process involved.  Although the 
other three species investigated did not demonstrate strong relationships, it may be due to 
the low sample size during data collection.  Furthermore, it appears that antibody 
activities are more sensitive than that of serum titers at 1:200 dilutions.  
Immunoprecipitation utilizing a protein G column, bottlenose dolphin purified 
IgG, and S. agalactiae lysate demonstrated interactions between antibody and antigen 
proteins.  The SDS-PAGE demonstrated four main proteins.  Two of the protein bands 
observed were identified as the heavy (~55kDa) and light (~ 25 kDa) chains of bottlenose 
dolphin IgG.  However, two bands of interest could not be identified by their molecular 
weights.  To remedy this, these proteins should be sent off for sequencing to characterize 
them.  Once identified and determined to be key immunogenic proteins against S.  
agalactiae, future efforts could be spent on developing a vaccine.  It has been noted that 
many streptococci are opportunistic pathogens (Blyth et al., 2013; Díaz-Delgado et al., 
2017; Louw and Tikly, 2007).  As the marine environment becomes more contaminated 
with pollutants and pathogens, this could lead to weakened and immunocompromised 
bottlenose dolphins, increasing their susceptibility to infectious disease (Numberger et 
al., 2021).  A vaccine could be useful to provide protection from future infections of S. 
agalactiae in bottlenose dolphin populations. 
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This study also provides baseline data for serum titer and antibody activity in the 
bottlenose dolphin against S. agalactiae.  Previous research has found that bottlenose 
dolphin individuals have had large enough exposures to result in titers against many 
different common marine bacteria (Beck and Rice, 2003; Bossart et al., 2008; Bossart et 
al., 2019; Fair et al., 2017).  These bacteria include Erysipelothrix rhusiopathiae, 
Escherichia coli, Mycobacterium marinum, Vibrio carchariae, Vibrio cholerae, Vibrio 
parahemolyticus, and Vibrio vulnificus.  Previous studies have reported immune 
responses in relative titers at a 1:200 dilution (Bossart et al., 2019) and antibody activity 
(units/µL) (Beck and Rice, 2003).  These are common bacteria, however, as human 
activities increase, more opportunistic bacteria such as S. agalactiae could begin to 
emerge and become more prevalent in the marine environment.  Prior studies have not 
investigated immune responses to S. agalactiae.  We measured serum antibody titers and 
antibody activities against S. agalactiae and found that dolphin samples were 
seropositive, demonstrating that these organisms have been exposed to quantities large 
enough to elicit an immune response.  The relationship between serum antibody titers and 
antibody activities was also investigated, and we found there to be a strong correlation for 
all samples as well as each population.  This allows for the conclusion that titers could 
indicate an approximate antibody activity and vice versa in bottlenose dolphins utilizing 
KA-6 and S. agalactiae.  Future research should investigate other data trends with sex, 
age, and toxicant burden or exposure.   
Wild dolphin populations are typically only sampled once.  Any sample analysis 
of that serum sample only provides data for that specific point in time.  In the case of 
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quantifying serum titers and antibody activity, it limits the researcher to that specific time 
point at serum collection.  It would be worthwhile to sample the same wild dolphins over 
a period of time to further understand the immune response over time.  With sampling 
conducted in that manner, we could observe to see if circulating antibodies or antibody 
activities increase or decrease for individuals.  We could then compare that data to water 
quality data to determine if the toxicant or pathogen load of that water has increased or 
decreased.  If the pathogen or toxicant load has increased in the marine environment, this 
could lead to dolphins and their immune systems being over inundated and possibly lead 
to immunosuppression.  This could increase the chances for opportunistic infections of S. 
agalactiae.  This could provide more insight into exposures to S. agalactiae and the 
likelihood of opportunistic exposures from S. agalactiae.  Furthermore, although it would 
be laborious, it would be interesting to investigate serum titers and antibody activities to 
previously studied pathogens to determine if similar patterns and relationships are 
present.   
Lastly, due to the abundance of bottlenose dolphin samples with a wide sampling 
date range and the generation of a monoclonal antibody against bottlenose dolphin IgG, it 
would be worthwhile to investigate serum antibody titers and antibody activities against 
the cetacean morbillivirus (CeMV).  The CeMV is highly contagious, lymphotropic, and 
initially replicates in lymphoid tissue before infecting epithelial cells (Shimizu et al., 
2013).  In addition, there have been several mortality events in coastal T.  truncatus 
populations from the Gulf of Mexico to the Atlantic coast of the United States since 1982 
(Krafft et al., 1995; Taubenberger et al., 1996).  Transmission of the morbillivirus is 
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thought to occur after the inhalation of airborne virus shed by cetacean individuals and is 
probable for cetaceans due to their sociable behavior and high density (Raga et al., 2008; 
Van Bressem et al., 1999).  Immunoglobulin M (IgM), immunoglobulin G (IgG), and 
immunoglobulin A (IgA) have been confirmed to be critical constituents of the marine 
mammal immune system to identify and aid in the destruction of invading pathogens 
such as the CeMV (Gelain and Bonsembiante, 2019).  From this study, we have 
successfully created a monoclonal antibody against bottlenose dolphin IgG, which is the 
major body of the secondary immune response which aids in the protection and immunity 
against future similar pathogens (Zimmerman et al., 2010).  In the future, we could 
quantify serum antibodies against the CeMV to gain more information about bottlenose 
dolphin memory immune responses and potential exposure events and associated 
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